Callaway, H. (1868). The Religious System of the Amazulu. Part I: Unkulunkulu; or, the Tradition of Creation as Existing among the Amazulu and Other Tribes of South Africa. Springvale, Natal: J. A. Blair.

Gantz, T. (1993). Early Greek Myth: A Guide to Literary and Artistic Sources. Baltimore: Johns Hopkins University Press.

West, M. L. (Ed. & Trans.). (2003). Homeric Hymns, Homeric Apocrypha, Lives of Homer. Cambridge, MA: Harvard University Press.

Fries, J. F. (1980). Aging, Natural Death, and the Compression of Morbidity. The New England Journal of Medicine, 303(3), 130–135.

Wilmoth, J. R., & Horiuchi, S. (1999). Rectangularization Revisited: Variability of Age at Death within Human Populations. Demography, 36(4), 475–495.

Oeppen, J., & Vaupel, J. W. (2002). Broken Limits to Life Expectancy. Science, 296(5570), 1029–1031.

World Health Organization. (2015). World Report on Ageing and Health. Geneva: World Health Organization.

Olshansky, S. J. (2018). From Lifespan to Healthspan. JAMA, 320(13), 1323–1324.

Attia, P., & Gifford, B. (2023). Outlive: The Science and Art of Longevity. New York: Harmony.

World Health Organization. (2025). World Health Statistics 2025: Monitoring Health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization.

Garmany, A., & Terzic, A. (2024). Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States. JAMA Network Open, 7(12), e2450241.

Medawar, P. B. (1952). An Unsolved Problem of Biology. London: H. K. Lewis.

Williams, G. C. (1957). Pleiotropy, Natural Selection, and the Evolution of Senescence. Evolution, 11(4), 398–411. doi:10.1111/j.1558-5646.1957.tb02911.x.

Rose, M. R. (1991). Evolutionary Biology of Aging. New York: Oxford University Press.

Rattan, S. I. S. (2014). Molecular Gerontology: From Homeodynamics to Hormesis. Current Pharmaceutical Design, 20(18), 3036–3039. doi:10.2174/13816128113196660708.

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The Hallmarks of Aging. Cell, 153(6), 1194–1217. doi:10.1016/j.cell.2013.05.039.

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of Aging: An Expanding Universe. Cell, 186(2), 243–278. doi:10.1016/j.cell.2022.11.001.

Yang, J. H., Hayano, M., Griffin, P. T., et al. (2023). Loss of Epigenetic Information as a Cause of Mammalian Aging. Cell, 186(2), 305–326.e27. doi:10.1016/j.cell.2022.12.027.

Timmons, J. A., & Brenner, C. (2024). The Information Theory of Aging Has Not Been Tested. Cell, 187(5), 1101–1102. doi:10.1016/j.cell.2024.01.013.

Tchkonia, T., & Kirkland, J. L. (2018). Aging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies. JAMA, 320(13), 1319–1320. doi:10.1001/jama.2018.12440.

Hackam, D. G., & Redelmeier, D. A. (2006). Translation of Research Evidence from Animals to Humans. JAMA, 296(14), 1731–1732. doi:10.1001/jama.296.14.1731.

National Academy of Medicine. (2022). Global Roadmap for Healthy Longevity. Washington, DC: The National Academies Press.

Gilgames. Magyar kiadás: Tertia Kiadó. Fordította Zászlós Levente. Elektronikus változat: Magyar Elektronikus Könyvtár, https://mek.oszk.hu/14700/14741/14741.pdf

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The Hallmarks of Aging. Cell, 153(6), 1194–1217.

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of Aging: An Expanding Universe. Cell, 186(2), 243–278.

Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ Metabolism and Its Roles in Cellular Processes During Ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141.

Hayflick, L., & Moorhead, P. S. (1961). The Serial Cultivation of Human Diploid Cell Strains. Experimental Cell Research, 25(3), 585–621.

Hayflick, L. (1965). The Limited In Vitro Lifetime of Human Diploid Cell Strains. Experimental Cell Research, 37(3), 614–636.

Shay, J. W., & Wright, W. E. (2019). Telomeres and Telomerase: Three Decades of Progress. Nature Reviews Genetics, 20(5), 299–309.

Fraga, M. F., et al. (2005). Epigenetic Differences Arise During the Lifetime of Monozygotic Twins. Proceedings of the National Academy of Sciences, 102(30), 10604–10609.

De Cecco, M., et al. (2019). L1 Drives IFN in Senescent Cells and Promotes Age-Associated Inflammation. Nature, 566, 73–78.

Simon, M., et al. (2019). LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation. Cell Metabolism, 29(2), 406–426.

Zhao, X., et al. (2021). The Interplay Among HIV, LINE-1, and the Interferon Signaling System. Frontiers in Immunology, 12, 732775.

Mehmood, A., et al. (2025). LINE-1 Retrotransposon Activation Drives Age-Associated Inflammation via Cytoplasmic cDNA–STING/Type I Interferon Signalling: Therapeutic Potential of Reverse Transcriptase Inhibition. Contemporary Oncology, 29(3), 240–246.

Franck, M., et al. (2025). Nonuniversality of Inflammaging Across Human Populations. Nature Aging, 5, 1471–1480.

Buttgereit, F., & Brand, M. D. (1995). A Hierarchy of ATP-Consuming Processes in Mammalian Cells. The Biochemical Journal, 312(Pt 1), 163–167.

Tiku, V., et al. (2017). Small Nucleoli Are a Cellular Hallmark of Longevity. Nature Communications, 8, 16083.

Kumar, A. V., et al. (2022). Exportin 1 Modulates Life Span by Regulating Nucleolar Dynamics via the Autophagy Protein LGG-1/GABARAP. Science Advances, 8(13), eabj1604.

Shore, D., & Albert, B. (2022). Ribosome Biogenesis and the Cellular Energy Economy. Current Biology, 32(12), R611–R617.

Hershko, A., Ciechanover, A., Heller, H., Haas, A. L., & Rose, I. A. (1980). Proposed Role of ATP in Protein Breakdown: Conjugation of Proteins with Multiple Chains of the Polypeptide of ATP-Dependent Proteolysis. Proceedings of the National Academy of Sciences of the United States of America, 77(4), 1783–1786.

Ciechanover, A., & Brundin, P. (2003). The Ubiquitin Proteasome System in Neurodegenerative Diseases: Sometimes the Chicken, Sometimes the Egg. Neuron, 40(2), 427–446.

Goldberg, A. L. (2003). Protein Degradation and Protection Against Misfolded or Damaged Proteins. Nature, 426(6968), 895–899.

Campone, M., et al. (2025). Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer. The New England Journal of Medicine, 393(6), 556–568.

U.S. Food and Drug Administration. (2026). FDA Approves Vepdegestrant for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer.

Tsukada, M., & Ohsumi, Y. (1993). Isolation and Characterization of Autophagy-Defective Mutants of Saccharomyces cerevisiae. FEBS Letters, 333(1–2), 169–174.

Terman, A., & Brunk, U. T. (2004). Lipofuscin. The International Journal of Biochemistry & Cell Biology, 36(8), 1400–1404.

Kovács, T., et al. (2013). The Protective Role of Autophagy in Aging. Gerontology, 59(4), 328–340.

Ramakrishnan, V. (2024). Why We Die: The New Science of Aging and the Quest for Immortality. William Morrow. Magyarul: Miért halunk meg? HVG Könyvek, 2024.

Coppé, J. P., et al. (2010). The Senescence-Associated Secretory Phenotype. Annual Review of Pathology, 5, 99–118.

Campisi, J. (2013). Aging, Cellular Senescence, and Cancer. Annual Review of Physiology, 75, 685–705.

Tchkonia, T., & Kirkland, J. L. (2018). Aging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies. JAMA, 320(13), 1319–1320.

Hao, X., et al. (2026). Nuclear Export of R-Loop by the DDX1 and XPO1 Complex Promotes Senescence-Associated Secretory Phenotype and Inflammaging. Nature Aging, 6, 1208–1226.

Han, S., et al. (2022). Low-Intensity Pulsed Ultrasound Alleviates Human Testicular Leydig Cell Senescence In Vitro. International Journal of Molecular Sciences, 24(1), 418.

Gwak, H., et al. (2025). Low-Intensity Pulsed Ultrasound Treatment Selectively Stimulates Senescent Cells to Promote SASP Factors for Immune Cell Recruitment. Aging Cell, e14486.

Han, W., et al. (2025). Low-Intensity Pulsed Ultrasound Inhibits Chondrocyte Senescence by Inhibiting PI3K/AKT/mTOR Signaling. Brazilian Journal of Medical and Biological Research, 58, e14408.

Martínez, D. E. (1998). Mortality Patterns Suggest Lack of Senescence in Hydra. Experimental Gerontology, 33(3), 217–225.

Schaible, R., et al. (2017). Hydra: Evolutionary and Biological Mechanisms for Non-Senescence. In R. P. Shefferson, O. R. Jones, & R. Salguero-Gómez (Eds.), The Evolution of Senescence in the Tree of Life (pp. 238–253). Cambridge University Press.

Lehallier, B., et al. (2019). Undulating Changes in Human Plasma Proteome Profiles Across the Lifespan Are Linked to Disease. Nature Medicine, 25(12), 1843–1850.

Shen, X., et al. (2024). Nonlinear Dynamics of Multi-Omics Profiles During Human Aging. Nature Aging, 4, 1619–1634.

Ding, Y., et al. (2025). Comprehensive Human Proteome Profiles Across a 50-Year Lifespan Reveal Aging Trajectories and Signatures. Cell, 188, 5763–5784.

Dong, W., et al. (2025). A Comprehensive Multi-Organ Proteomic Atlas of Human Aging Across 50 Years. Protein & Cell, pwaf081.

Medawar, P. B. (1952). An Unsolved Problem of Biology. H. K. Lewis.

Williams, G. C. (1957). Pleiotropy, Natural Selection, and the Evolution of Senescence. Evolution, 11(4), 398–411.

Rose, M. R. (1982). Antagonistic Pleiotropy, Dominance, and Genetic Variation. Heredity, 48, 63–78.

Rose, M. R. (1985). Life History Evolution with Antagonistic Pleiotropy and Overlapping Generations. Theoretical Population Biology, 28, 342–358.

Rose, M. R. (1991). Evolutionary Biology of Aging. Oxford University Press.

Shefferson, R. P., Jones, O. R., & Salguero-Gómez, R. (2017). Introduction: Wilting Leaves and Rotting Branches. In R. P. Shefferson, O. R. Jones, & R. Salguero-Gómez (Eds.), The Evolution of Senescence in the Tree of Life (pp. 1–20). Cambridge University Press.

Mitteldorf, J. (2019). What Is Antagonistic Pleiotropy? Biochemistry (Moscow), 84(12), 1458–1468.

Roget, T., et al. (2024). A Scenario for an Evolutionary Selection of Ageing. eLife, 13, RP92914.

Cattaneo, M., et al. (2026). Decoding Human Longevity: Genetic and Molecular Insights from Accelerated to Successful Ageing. Ageing Research Reviews, 119, 103176.

Ruby, J. G., Wright, K. M., Rand, K. A., et al. (2018). Estimates of the Heritability of Human Longevity Are Substantially Inflated due to Assortative Mating. Genetics, 210(3), 1109–1124. doi:10.1534/genetics.118.301613.
– A klasszikusnál jóval alacsonyabb örökölhetőségi becslések és az asszortatív párválasztás torzító szerepe.

Shenhar, B., Pridham, G., De Oliveira, T. L., Raz, N., Yang, Y., Deelen, J., Hägg, S., & Alon, U. (2026).Heritability of Intrinsic Human Life Span Is About 50% When Confounding Factors Are Addressed. Science, 391(6784), 504–510. doi:10.1126/science.adz1187.
– A 2026-os, lényegesen magasabb becslés; éppen ezért fontos a könyvben hangsúlyozni, hogy az örökölhetőség mértéke módszertani definícióktól is függ.

Deelen, J., Evans, D. S., Arking, D. E., et al. (2019). A Meta-Analysis of Genome-Wide Association Studies Identifies Multiple Longevity Genes. Nature Communications, 10, 3669. doi:10.1038/s41467-019-11558-2.
– APOE, további genetikai loci, valamint a hosszú élet és az életkorral összefüggő betegségek közös genetikai architektúrája.

Timmers, P. R. H. J., Wilson, J. F., Joshi, P. K., & Deelen, J. (2020). Multivariate Genomic Scan Implicates Novel Loci and Haem Metabolism in Human Ageing. Nature Communications, 11, 3570. doi:10.1038/s41467-020-17312-3.
– Healthspan, szülői élettartam és kivételes hosszú élet együttes genetikai elemzése; jól mutatja a sok kis hatásból összeálló képet.

Jensson, B. O., Arnadottir, G. A., Katrinardottir, H., et al. (2023). Actionable Genotypes and Their Association with Life Span in Iceland. The New England Journal of Medicine, 389, 1741–1752. doi:10.1056/NEJMoa2300792.
– Különösen hasznos a ritka, klinikailag cselekvést lehetővé tevő patogén variánsok és az élettartam kapcsolatának bemutatásához.

Khera, A. V., Chaffin, M., Aragam, K. G., et al. (2018). Genome-Wide Polygenic Scores for Common Diseases Identify Individuals with Risk Equivalent to Monogenic Mutations. Nature Genetics, 50, 1219–1224. doi:10.1038/s41588-018-0183-z.
– Alapvető tanulmány annak bemutatására, hogyan sűríthető sok gyakori variáns kis hatása poligénes kockázati pontszámmá.

Lennon, N. J., Kottyan, L. C., Kachulis, C., et al. (2024). Selection, Optimization and Validation of Ten Chronic Disease Polygenic Risk Scores for Clinical Implementation in Diverse US Populations. Nature Medicine, 30, 480–487. doi:10.1038/s41591-024-02796-z.
– A PRS-ek klinikai használhatósága, validálása és eltérő populációkban való alkalmazása.

Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019). Clinical Use of Current Polygenic Risk Scores May Exacerbate Health Disparities. Nature Genetics, 51, 584–591. doi:10.1038/s41588-019-0379-x.
– A genetikai adatbázisok európai túlsúlya és a poligénes pontszámok populációk közötti gyengébb átvihetősége miatt fontos.

Richards, S., Aziz, N., Bale, S., et al. (2015). Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405–423. doi:10.1038/gim.2015.30.
– A patogén, valószínűleg patogén, bizonytalan jelentőségű, valószínűleg jóindulatú és jóindulatú variánsok értelmezésének alapvető rendszere.

Mitchell, S. J., et al. (2015). Animal Models of Aging Research: Implications for Human Aging and Age-Related Diseases. Annual Review of Animal Biosciences, 3, 283–303.

Agoston, D. V. (2017). How to Translate Time? The Temporal Aspect of Human and Rodent Biology. Frontiers in Neurology, 8, 92.

Ganeshan, K., & Chawla, A. (2017). Warming the Mouse to Model Human Diseases. Nature Reviews Endocrinology, 13, 458–465.

Plutarch. (1936). Isis and Osiris. In Moralia, Vol. V. Translated by F. C. Babbitt. Loeb Classical Library 306. Cambridge, MA: Harvard University Press.

British Museum. (é. n.). Papyrus: Book of the Dead of Ani, Frame 30. EA10470,30. London: British Museum.

Horvath, S. (2013). DNA Methylation Age of Human Tissues and Cell Types. Genome Biology, 14(10), R115.

Hannum, G., et al. (2013). Genome-Wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates. Molecular Cell, 49(2), 359–367.

Krištić, J., et al. (2014). Glycans Are a Novel Biomarker of Chronological and Biological Ages. The Journals of Gerontology: Series A, 69(7), 779–789.

Bobrov, E., et al. (2018). PhotoAgeClock: Deep Learning Algorithms for Development of Non-Invasive Visual Biomarkers of Aging. Aging, 10(11), 3249–3259.

Gudelj, I., Lauc, G., & Pezer, M. (2018). Immunoglobulin G Glycosylation in Aging and Disease. Cellular Immunology, 333, 65–79.

Lu, A. T., et al. (2019). DNA Methylation GrimAge Strongly Predicts Lifespan and Healthspan. Aging, 11(2), 303–327.

Belsky, D. W., et al. (2022). DunedinPACE, a DNA Methylation Biomarker of the Pace of Aging. eLife, 11, e73420.

Oh, H. S.-H., et al. (2023). Organ Aging Signatures in the Plasma Proteome Track Health and Disease. Nature, 624, 164–172.

Mamoshina, P., & Zhavoronkov, A. (2024). Artificial Intelligence in Aging and Longevity. In G. J. Simon & C. Aliferis (Eds.), Artificial Intelligence and Machine Learning in Health Care (pp. 313–333). Springer.

Furrer, R., & Handschin, C. (2025). Biomarkers of Aging: Functional Aspects Still Trump Molecular Parameters. npj Aging, 11, 15.

Wang, Y., et al. (2026). Organ-Specific Proteomic Aging Clocks Predict Disease and Mortality. Nature Aging, 6, 162–180.

Pai, V. P., et al. (2012). Transmembrane Voltage Potential Controls Embryonic Eye Patterning in Xenopus laevis. Development, 139(2), 313–323.

Blackiston, D. J., & Levin, M. (2013). Ectopic Eyes Outside the Head in Xenopus Tadpoles Provide Sensory Data for Light-Mediated Learning. Journal of Experimental Biology, 216(Pt 6), 1031–1040.

Levin, M. (2014). Molecular Bioelectricity: How Endogenous Voltage Potentials Control Cell Behavior. Molecular Biology of the Cell, 25(24), 3835–3850.

Levin, M., Pietak, A. M., & Bischof, J. (2019). Planarian Regeneration as a Model of Anatomical Homeostasis: Recent Progress in Biophysical and Computational Approaches. Seminars in Cell & Developmental Biology, 87, 125–144.

McCusker, C., & Gardiner, D. M. (2011). The Axolotl Model for Regeneration and Aging Research. Gerontology, 57(6), 565–571.

Tomasek, J. J., et al. (2002). Myofibroblasts and Mechano-Regulation of Connective Tissue Remodelling. Nature Reviews Molecular Cell Biology, 3(5), 349–363.

Verzijl, N., et al. (2002). Crosslinking by Advanced Glycation End Products Increases the Stiffness of the Collagen Network in Human Articular Cartilage. Arthritis & Rheumatism, 46(1), 114–123.

Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006). Matrix Elasticity Directs Stem Cell Lineage Specification. Cell, 126(4), 677–689.

Dupont, S., et al. (2011). Role of YAP/TAZ in Mechanotransduction. Nature, 474, 179–183.

Uhler, C., & Shivashankar, G. V. (2017). Regulation of Genome Organization and Gene Expression by Nuclear Mechanotransduction. Nature Reviews Molecular Cell Biology, 18(12), 717–727.

Ott, H. C., et al. (2008). Perfusion-Decellularized Matrix: Using Nature’s Platform to Engineer a Bioartificial Heart. Nature Medicine, 14, 213–221.

Pawan, K. C., Hong, Y., & Zhang, G. (2019). Cardiac Tissue-Derived Extracellular Matrix Scaffolds for Myocardial Repair: Advantages and Challenges. Regenerative Biomaterials, 6(4), 185–199.

Langer, R., & Vacanti, J. P. (1993). Tissue Engineering. Science, 260(5110), 920–926.

Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal Stem Cells as Trophic Mediators. Journal of Cellular Biochemistry, 98(5), 1076–1084.

Fischer, U. M., et al. (2009). Pulmonary Passage Is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect. Stem Cells and Development, 18(5), 683–692.

Murphy, S. V., & Atala, A. (2014). 3D Bioprinting of Tissues and Organs. Nature Biotechnology, 32(8), 773–785.

Lyons, S., Salgaonkar, S., & Flaherty, G. T. (2022). International Stem Cell Tourism: A Critical Literature Review and Evidence-Based Recommendations. International Health, 14(2), 132–141.

Lener, T., et al. (2015). Applying Extracellular Vesicles Based Therapeutics in Clinical Trials: An ISEV Position Paper. Journal of Extracellular Vesicles, 4(1), 30087.

Théry, C., et al. (2018). Minimal Information for Studies of Extracellular Vesicles 2018: MISEV2018. Journal of Extracellular Vesicles, 7(1), 1535750.

U.S. Food and Drug Administration. (2019. december 6.). Public Safety Notification on Exosome Products. FDA.

Bai, G., et al. (2024). Clinical Applications of Exosomes in Cosmetic Dermatology. Skin Health and Disease, 4(6), e348.

Fosgerau, K., & Hoffmann, T. (2015). Peptide Therapeutics: Current Status and Future Directions. Drug Discovery Today, 20(1), 122–128.

Lee, C., et al. (2015). The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism, 21(3), 443–454.

Lau, J. L., & Dunn, M. K. (2018). Therapeutic Peptides: Historical Perspectives, Current Development Trends, and Future Directions. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707.

Gwyer, D., Wragg, N. M., & Wilson, S. L. (2019). Gastric Pentadecapeptide Body Protection Compound BPC 157 and Its Role in Accelerating Musculoskeletal Soft Tissue Healing. Cell and Tissue Research, 377(2), 153–159.

Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in Peptide Drug Discovery. Nature Reviews Drug Discovery, 20(4), 309–325.

Hao, Z. W., et al. (2024). Bioactive Peptides and Proteins for Tissue Repair. International Journal of Biological Macromolecules, 278, 134837.

Deschamps, J.-Y., et al. (2005). History of Xenotransplantation. Xenotransplantation, 12(2), 91–109.

Cooper, D. K. C. (2012). A Brief History of Cross-Species Organ Transplantation. Baylor University Medical Center Proceedings, 25(1), 49–57.

Cooper, D. K. C., Ekser, B., & Tector, A. J. (2015). A Brief History of Clinical Xenotransplantation. International Journal of Surgery, 23(Pt B), 205–210.

United Therapeutics. (2025. november 3.). United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients with End-Stage Renal Disease.

United Therapeutics. (2025. február 3.). United Therapeutics Corporation Announces FDA Clearance of Its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial.

Sheridan, C. (2025). Longest Animal-to-Human Transplant. Nature Biotechnology, 43, 1750.

ClinicalTrials.gov. (2026). Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-Stage Renal Disease. NCT06878560.

ClinicalTrials.gov. (2026). Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With End-Stage Renal Disease. NCT07224763.

Olaisen, B. F., et al. (2026). Replacement-Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions. Aging Cell, 25(5), e70516.

Ovidius. Átváltozások, I. könyv, Ió és Argosz története. Különböző magyar kiadásokban.

Franceschi, C., et al. (2000). Inflamm-Aging: An Evolutionary Perspective on Immunosenescence. Annals of the New York Academy of Sciences, 908, 244–254.

Naylor, K., et al. (2005). The Influence of Age on T Cell Generation and TCR Diversity. The Journal of Immunology, 174(11), 7446–7452.

Nikolich-Zugich, J. (2008). Ageing and Life-Long Maintenance of T-Cell Subsets in the Face of Latent Persistent Infections. Nature Reviews Immunology, 8(7), 512–522.

Steinmann, G. G., Klaus, B., & Müller-Hermelink, H. K. (1985). The Involution of the Ageing Human Thymic Epithelium Is Independent of Puberty: A Morphometric Study. Scandinavian Journal of Immunology, 22(5), 563–575.

Douek, D. C., et al. (1998). Changes in Thymic Function with Age and During the Treatment of HIV Infection. Nature, 396(6712), 690–695.

Palmer, D. B. (2013). The Effect of Age on Thymic Function. Frontiers in Immunology, 4, 316.

Fahy, G. M., et al. (2019). Reversal of Epigenetic Aging and Immunosenescent Trends in Humans. Aging Cell, 18(6), e13028.

ClinicalTrials.gov. (2026). Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X). NCT04375657.

Feige, M. J., et al. (2014). The Structural Analysis of Shark IgNAR Antibodies Reveals Evolutionary Principles of Immunoglobulins. Proceedings of the National Academy of Sciences of the United States of America, 111(22), 8155–8160.

Juma, S. N., et al. (2021). Shark New Antigen Receptor: Structure, Characteristics and Potential Biomedical Applications. Cells, 10(5), 1140.

Olivares-Olivares, R. A., et al. (2026). VNAR: Shark Single-Domain Antibodies for the New Era of Medical Biotechnology. Frontiers in Immunology, 16, 1716916.

Cho, R. H., Sieburg, H. B., & Muller-Sieburg, C. E. (2008). A New Mechanism for the Aging of Hematopoietic Stem Cells: Aging Changes the Clonal Composition of the Stem Cell Compartment but Not Individual Stem Cells. Blood, 111(12), 5553–5561.

Beerman, I., et al. (2010). Functionally Distinct Hematopoietic Stem Cells Modulate Hematopoietic Lineage Potential During Aging by a Mechanism of Clonal Expansion. Proceedings of the National Academy of Sciences of the United States of America, 107(12), 5465–5470.

Pang, W. W., et al. (2011). Hematopoietic Stem Cell Aging Is Characterized by Differential Clonal Expansion and Granulocyte-Biased Differentiation. Proceedings of the National Academy of Sciences of the United States of America, 108(50), 20012–20017.

Klenerman, P., & Oxenius, A. (2016). T Cell Responses to Cytomegalovirus. Nature Reviews Immunology, 16(6), 365–377.

Fowler, K., et al. (2022). A Systematic Literature Review of the Global Seroprevalence of Cytomegalovirus: Possible Implications for Treatment, Screening, and Vaccine Development. BMC Public Health, 22, 1659.

Freeman, G. J., et al. (2000). Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation. The Journal of Experimental Medicine, 192(7), 1027–1034.

Dong, H., et al. (2002). Tumor-Associated B7-H1 Promotes T-Cell Apoptosis: A Potential Mechanism of Immune Evasion. Nature Medicine, 8(8), 793–800.

Dunn, G. P., et al. (2002). Cancer Immunoediting: From Immunosurveillance to Tumor Escape. Nature Immunology, 3(11), 991–998.

Pardoll, D. M. (2012). The Blockade of Immune Checkpoints in Cancer Immunotherapy. Nature Reviews Cancer, 12(4), 252–264.

Sharma, P., & Allison, J. P. (2015). The Future of Immune Checkpoint Therapy. Science, 348, 56–61.

Heneka, M. T., et al. (2013). NLRP3 Is Activated in Alzheimer’s Disease. Nature, 493, 674–678.

Goldberg, E. L., & Dixit, V. D. (2015). Drivers of Age-Related Inflammation and Strategies for Healthspan Extension. Immunological Reviews, 265(1), 63–74.

Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019). The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics. Nature Reviews Immunology, 19, 477–489.

Sansoni, P., et al. (2008). The Immune System in Extreme Longevity. Experimental Gerontology, 43(2), 61–65.

Sakaguchi, S., et al. (2008). Regulatory T Cells and Immune Tolerance. Cell, 133(5), 775–787.

Garg, S. K., et al. (2014). Aging Is Associated with Increased Regulatory T-Cell Function. Aging Cell, 13(3), 441–448.

Cunningham, A. L., McIntyre, P., Subbarao, K., Booy, R., & Levin, M. J. (2021). Vaccines for Older Adults. BMJ, 372, n188.

Hou, Y., et al. (2024). Insights into Vaccines for Elderly Individuals: From the Impacts of Immunosenescence to Delivery Strategies. npj Vaccines, 9, 77.

Centers for Disease Control and Prevention. (2025, 2026-os kiegészítésekkel). Adult Immunization Schedule. A konkrét ajánlásokat a könyv online frissítésében kell naprakészen tartani.

Nemzeti Népegészségügyi és Gyógyszerészeti Központ. (2026). Felnőttkori védőoltások ütemezésének ajánlása 2026.

Li, Q., et al. (2008). Visiting a Forest, but Not a City, Increases Human Natural Killer Activity and Expression of Anti-Cancer Proteins. International Journal of Immunopathology and Pharmacology, 21(1), 117–127.

Li, Q., et al. (2009). Effect of Phytoncide from Trees on Human Natural Killer Cell Function. International Journal of Immunopathology and Pharmacology, 22(4), 951–959.

Li, Q. (2010). Effect of Forest Bathing Trips on Human Immune Function. Environmental Health and Preventive Medicine, 15(1), 9–17.

Tsao, T.-M., et al. (2018). Health Effects of a Forest Environment on Natural Killer Cells in Humans: An Observational Pilot Study. Oncotarget, 9, 16501–16511.

Scallan, J. P., et al. (2016). Lymphatic Pumping: Mechanics, Mechanisms and Malfunction. The Journal of Physiology, 594(20), 5749–5768.

Moore, J. E., & Bertram, C. D. (2018). Lymphatic System Flows. Annual Review of Fluid Mechanics, 50, 459–482.

Simpson, R. J., et al. (2015). Exercise and the Regulation of Immune Functions. Progress in Molecular Biology and Translational Science, 135, 355–380.

Lange, T., Perras, B., Fehm, H. L., & Born, J. (2003). Sleep Enhances the Human Antibody Response to Hepatitis A Vaccination. Psychosomatic Medicine, 65(5), 831–835.

Spiegel, K., et al. (2023). A Meta-Analysis of the Associations Between Insufficient Sleep Duration and Antibody Response to Vaccination. Current Biology, 33(5), 998–1005.e2.

Cheng, C. W., et al. (2014). Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression. Cell Stem Cell, 14(6), 810–823.

Mukama, T., et al. (2023). IGF-1 and Risk of Morbidity and Mortality from Cancer, Cardiovascular Diseases, and All Causes in EPIC-Heidelberg. The Journal of Clinical Endocrinology & Metabolism, 108(10), e1092–e1105.

Czerniuk, M., et al. (2022). Unexpected Relationships: Periodontal Diseases, Atherosclerosis and Plaque Destabilization? From the Teeth to a Coronary Event. Biology, 11(2), 272.

Ruan, Q., et al. (2023). Porphyromonas gingivalis Regulates Atherosclerosis Through an Immune Pathway. Frontiers in Immunology, 14, 1103592.

Dibello, V., Custodero, C., Cavalcanti, R., et al. (2024). Impact of Periodontal Disease on Cognitive Disorders, Dementia, and Depression: A Systematic Review and Meta-Analysis. GeroScience, 46(5), 5133–5169.

Kohn, L. (2009). Introducing Daoism. London–New York: Routledge.

Bass, J., & Takahashi, J. S. (2010). Circadian Integration of Metabolism and Energetics. Science, 330(6009), 1349–1354.

Hood, S., & Amir, S. (2017). The Aging Clock: Circadian Rhythms and Later Life. The Journal of Clinical Investigation, 127(2), 437–446.

Bargiello, T. A., et al. (1984). Restoration of Circadian Behavioural Rhythms by Gene Transfer in Drosophila. Nature, 312, 752–754.

Damiola, F., et al. (2000). Restricted Feeding Uncouples Circadian Oscillators in Peripheral Tissues from the Central Pacemaker in the Suprachiasmatic Nucleus. Genes & Development, 14(23), 2950–2961.

Reppert, S. M., & Weaver, D. R. (2001). Molecular Analysis of Mammalian Circadian Rhythms. Annual Review of Physiology, 63, 647–676.

Buhr, E. D., Yoo, S.-H., & Takahashi, J. S. (2010). Temperature as a Universal Resetting Cue for Mammalian Circadian Oscillators. Science, 330(6002), 379–385.

Nobel Assembly at Karolinska Institutet. (2017). The 2017 Nobel Prize in Physiology or Medicine: Discoveries of Molecular Mechanisms Controlling the Circadian Rhythm. Nobel Prize.

Panda, S. (2018). The Circadian Code. Rodale Books.

Brainard, G. C., et al. (2001). Action Spectrum for Melatonin Regulation in Humans. The Journal of Neuroscience, 21(16), 6405–6412.

Hattar, S., et al. (2002). Melanopsin-Containing Retinal Ganglion Cells: Architecture, Projections, and Intrinsic Photosensitivity. Science, 295(5557), 1065–1070.

Haghayegh, S., et al. (2019). Before-Bedtime Passive Body Heating by Warm Shower or Bath to Improve Sleep: A Systematic Review and Meta-Analysis. Sleep Medicine Reviews, 46, 124–135.

Frimpong, E., et al. (2021). The Effects of Evening High-Intensity Exercise on Sleep in Healthy Adults: A Systematic Review and Meta-Analysis. Sleep Medicine Reviews, 60, 101535.

Borbély, A. A. (1982). A Two Process Model of Sleep Regulation. Human Neurobiology, 1(3), 195–204.

Daan, S., Beersma, D. G. M., & Borbély, A. A. (1984). Timing of Human Sleep: Recovery Process Gated by a Circadian Pacemaker. American Journal of Physiology, 246(2 Pt 2), R161–R183.

Drake, C., Roehrs, T., Shambroom, J., & Roth, T. (2013). Caffeine Effects on Sleep Taken 0, 3, or 6 Hours Before Going to Bed. Journal of Clinical Sleep Medicine, 9(11), 1195–1200.

Walker, M. (2017). Why We Sleep: Unlocking the Power of Sleep and Dreams. Scribner. Magyarul: Miért alszunk? HVG Könyvek, 2017.

Tamm, A. S., et al. (2009). Chronotype Influences Diurnal Variations in the Excitability of the Human Motor Cortex and the Ability to Generate Torque During a Maximum Voluntary Contraction. Journal of Biological Rhythms, 24(3), 211–224.

Ekirch, A. R. (2001). Sleep We Have Lost: Pre-Industrial Slumber in the British Isles. The American Historical Review, 106(2), 343–386.

Ekirch, A. R. (2005). At Day’s Close: Night in Times Past. W. W. Norton & Company.

Samson, D. R., et al. (2017). Segmented Sleep in a Nonelectric, Small-Scale Agricultural Society in Madagascar. American Journal of Human Biology, 29(4), e22979.

Bódizs, R., et al. (2005). Aging and Sleep: A Developmental Study. Sleep, 28, 1–12.

Roenneberg, T., et al. (2012). Social Jetlag and Obesity. Current Biology, 22(10), 939–943.

Boivin, D. B., Boudreau, P., & Kosmadopoulos, A. (2022). Disturbance of the Circadian System in Shift Work and Its Health Impact. Journal of Biological Rhythms, 37(1), 3–28.

Dallmann, R., Brown, S. A., & Gachon, F. (2014). Chronopharmacology: New Insights and Therapeutic Implications. Annual Review of Pharmacology and Toxicology, 54, 339–361.

Hermida, R. C., et al. (2020). Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: The Hygia Chronotherapy Trial. European Heart Journal, 41(48), 4565–4576.

Mackenzie, I. S., et al. (2022). Cardiovascular Outcomes in Adults with Hypertension with Evening versus Morning Dosing of Usual Antihypertensives in the UK: The TIME Study. The Lancet, 400(10361), 1417–1425.

Maqsood, M. H., et al. (2023). Timing of Antihypertensive Drug Therapy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hypertension, 80, 1544–1554.

Dopico, X. C., et al. (2015). Widespread Seasonal Gene Expression Reveals Annual Differences in Human Immunity. Nature Communications, 6, 7000.

Iliff, J. J., et al. (2012). A Paravascular Pathway Facilitating CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes. Science Translational Medicine, 4(147), 147ra111.

Xie, L., et al. (2013). Sleep Drives Metabolite Clearance from the Adult Brain. Science, 342(6156), 373–377.

Fultz, N. E., et al. (2019). Coupled Electrophysiological, Hemodynamic, and Cerebrospinal Fluid Oscillations in Human Sleep. Science, 366(6465), 628–631.

Marshall, N. S., et al. (2008). Sleep Apnea as an Independent Risk Factor for All-Cause Mortality: The Busselton Health Study. Sleep, 31(8), 1079–1085.

Kapur, V. K., et al. (2017). Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine, 13(3), 479–504.

Patil, S. P., et al. (2019). Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine, 15(2), 335–343.

Dedhia, R. C., et al. (2024). Hypoglossal Nerve Stimulation and Cardiovascular Outcomes for Patients with Obstructive Sleep Apnea. JAMA Otolaryngology–Head & Neck Surgery, 150, 39–48.

Mouritsen, H. (2018). Magnetoreception in Birds. In Bird Migration Across the Himalayas. Cambridge University Press.

Wiltschko, R., Nießner, C., & Wiltschko, W. (2021). The Magnetic Compass of Birds: The Role of Cryptochrome. Frontiers in Physiology, 12, 667000.

Kavet, R., & Brain, J. (2021). Cryptochromes in Mammals and Birds: Clock or Magnetic Compass? Physiology, 36(3), 183–194.

Snorri Sturluson. (1995). Edda. Translated and edited by Anthony Faulkes. London: Everyman.

Cannon, W. B. (1932). The Wisdom of the Body. New York: W. W. Norton.

Lloyd, D., Aon, M. A., & Cortassa, S. (2001). Why Homeodynamics, Not Homeostasis? The Scientific World Journal, 1, 133–145.

Rattan, S. I. S. (2006). Theories of Biological Aging: Genes, Proteins, and Free Radicals. Free Radical Research, 40(12), 1230–1238.

Sterling, P., & Eyer, J. (1988). Allostasis: A New Paradigm to Explain Arousal Pathology. In S. Fisher & J. Reason (Eds.), Handbook of Life Stress, Cognition and Health (pp. 629–649). Chichester: Wiley.

McEwen, B. S., & Stellar, E. (1993). Stress and the Individual: Mechanisms Leading to Disease. Archives of Internal Medicine, 153(18), 2093–2101.

McEwen, B. S. (1998). Protective and Damaging Effects of Stress Mediators. The New England Journal of Medicine, 338(3), 171–179.

Juster, R.-P., McEwen, B. S., & Lupien, S. J. (2010). Allostatic Load Biomarkers of Chronic Stress and Impact on Health and Cognition. Neuroscience & Biobehavioral Reviews, 35(1), 2–16.

Seeman, T. E., McEwen, B. S., Rowe, J. W., & Singer, B. H. (2001). Allostatic Load as a Marker of Cumulative Biological Risk: MacArthur Studies of Successful Aging. Proceedings of the National Academy of Sciences of the United States of America, 98(8), 4770–4775.

Selye, H. (1936). A Syndrome Produced by Diverse Nocuous Agents. Nature, 138, 32.

Selye, H. (1950). Stress and the General Adaptation Syndrome. British Medical Journal, 1(4667), 1383–1392.

Taleb, N. N. (2012). Antifragile: Things That Gain from Disorder. New York: Random House.

Rattan, S. I. S. (2008). Hormesis in Aging. Ageing Research Reviews, 7(1), 63–78.

Calabrese, E. J., & Baldwin, L. A. (2003). Hormesis: The Dose–Response Revolution. Annual Review of Pharmacology and Toxicology, 43, 175–197.

Thaler, J. P., et al. (2012). Obesity Is Associated with Hypothalamic Injury in Rodents and Humans. The Journal of Clinical Investigation, 122(1), 153–162.

Zhang, G., Li, J., et al. (2013). Hypothalamic Programming of Systemic Ageing Involving IKK-β, NF-κB and GnRH. Nature, 497(7448), 211–216.

Myers, M. G., Jr., Cowley, M. A., & Münzberg, H. (2008). Mechanisms of Leptin Action and Leptin Resistance. Annual Review of Physiology, 70, 537–556.

Adam, E. K., et al. (2017). Diurnal Cortisol Slopes and Mental and Physical Health Outcomes: A Systematic Review and Meta-analysis. Psychoneuroendocrinology, 83, 25–41.

Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart Rate Variability: Standards of Measurement, Physiological Interpretation and Clinical Use. Circulation, 93(5), 1043–1065.

Kleiger, R. E., et al. (1987). Decreased Heart Rate Variability and Its Association with Increased Mortality After Acute Myocardial Infarction. The American Journal of Cardiology, 59(4), 256–262.

Thayer, J. F., et al. (2010). The Relationship of Autonomic Imbalance, Heart Rate Variability and Cardiovascular Disease Risk Factors. International Journal of Cardiology, 141(2), 122–131.

Lehrer, P. M., et al. (2003). Heart Rate Variability Biofeedback Increases Baroreflex Gain and Peak Expiratory Flow. Psychosomatic Medicine, 65(5), 796–805.

Lehrer, P. M., & Gevirtz, R. (2014). Heart Rate Variability Biofeedback: How and Why Does It Work? Frontiers in Psychology, 5, 756.

Georgiou, K., et al. (2018). Can Wearable Devices Accurately Measure Heart Rate Variability? A Systematic Review. Folia Medica, 60(1), 7–20.

Li, K., et al. (2023). Heart Rate Variability Measurement through a Smart Wearable Device: Another Breakthrough for Personal Health Monitoring? International Journal of Environmental Research and Public Health, 20(24), 7146.

Nattie, E. (1999). CO₂, Brainstem Chemoreceptors and Breathing. Progress in Neurobiology, 59(4), 299–331.

Laukkanen, T., et al. (2015). Association Between Sauna Bathing and Fatal Cardiovascular and All-Cause Mortality Events. JAMA Internal Medicine, 175(4), 542–548.

Laukkanen, J. A., Laukkanen, T., & Kunutsor, S. K. (2018). Cardiovascular and Other Health Benefits of Sauna Bathing: A Review of the Evidence. Mayo Clinic Proceedings, 93(8), 1111–1121.

Tipton, M. J., Collier, N., Massey, H., Corbett, J., & Harper, M. (2017). Cold Water Immersion: Kill or Cure? Experimental Physiology, 102(11), 1335–1355.

Serebrovskaya, T. V., et al. (2016). Intermittent Hypoxia: From Molecular Mechanisms to Clinical Applications. Current Medicinal Chemistry, 23(18), 1797–1816.

Dempsey, J. A., Veasey, S. C., Morgan, B. J., & O’Donnell, C. P. (2010). Pathophysiology of Sleep Apnea. Physiological Reviews, 90(1), 47–112.

Moon, R. E. (Ed.). (2020). Hyperbaric Oxygen Therapy Indications (15th ed.). North Palm Beach, FL: Best Publishing Company for the Undersea and Hyperbaric Medical Society.

Hachmo, Y., et al. (2020). Hyperbaric Oxygen Therapy Increases Telomere Length and Decreases Immunosenescence in Isolated Blood Cells: A Prospective Trial. Aging, 12(22), 22445–22456.

McKeown, P. (2015). The Oxygen Advantage. New York: William Morrow. Magyarul: A légzés ereje. Budapest: Jaffa Kiadó, 2016.

Saito, M., et al. (2009). High Incidence of Metabolically Active Brown Adipose Tissue in Healthy Adult Humans. Diabetes, 58(7), 1526–1531.

Hanssen, M. J. W., et al. (2015). Short-Term Cold Acclimation Improves Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus. Nature Medicine, 21(8), 863–865.

Peretti, D., et al. (2015). RBM3 Mediates Structural Plasticity and Protective Effects of Cooling in Neurodegeneration. Nature, 518(7538), 236–239.

Bieuzen, F., Bleakley, C. M., & Costello, J. T. (2013). Contrast Water Therapy and Exercise Induced Muscle Damage: A Systematic Review and Meta-analysis. PLOS ONE, 8(4), e62356.

Homeric Hymn 32. To Selene. In M. L. West (Trans.), Homeric Hymns, Homeric Apocrypha, Lives of Homer. Loeb Classical Library 496. Harvard University Press, 2003.

Clayton, J. A., & Collins, F. S. (2014). Policy: NIH to Balance Sex in Cell and Animal Studies. Nature, 509, 282–283.

Liu, K. A., & DiPietro Mager, N. A. (2016). Women’s Involvement in Clinical Trials: Historical Perspective and Future Implications. Pharmacy Practice, 14(1), 708.

Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009). Ovarian Aging: Mechanisms and Clinical Consequences. Endocrine Reviews, 30(5), 465–493.

Wallace, W. H. B., & Kelsey, T. W. (2010). Human Ovarian Reserve from Conception to the Menopause. PLOS ONE, 5(1), e8772.

Steiner, A. Z., et al. (2017). Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA, 318(14), 1367–1376.

Sun, F., et al. (2015). Extended Maternal Age at Birth of Last Child and Women’s Longevity in the Long Life Family Study. Menopause, 22(1), 26–31.

Harlow, S. D., et al. (2012). Executive Summary of the Stages of Reproductive Aging Workshop +10: Addressing the Unfinished Agenda of Staging Reproductive Aging. Menopause, 19(4), 387–395.

Reed, B. G., & Carr, B. R. (2018). The Normal Menstrual Cycle and the Control of Ovulation. In Endotext. MDText.com.

Janse de Jonge, X. A. K., et al. (2019). Methodological Recommendations for Menstrual Cycle Research in Sports and Exercise. Medicine & Science in Sports & Exercise, 51(12), 2610–2617.

McNulty, K. L., et al. (2020). The Effects of Menstrual Cycle Phase on Exercise Performance in Eumenorrheic Women: A Systematic Review and Meta-Analysis. Sports Medicine, 50, 1813–1827.

Tucker, J. A. L., et al. (2025). The Effect of the Menstrual Cycle on Energy Intake: A Systematic Review and Meta-Analysis. Nutrition Reviews, 83(3), e866–e876.

Mountjoy, M., et al. (2023). 2023 International Olympic Committee’s Consensus Statement on Relative Energy Deficiency in Sport (REDs). British Journal of Sports Medicine, 57(17), 1073–1097.

Garrison, J. L. (2026). Beyond Reproduction: The Ovary as a Systemic Regulator of Female Health and Aging. PLOS Biology, 24(5), e3003800.

Chiavellini, P., & Sebastiano, V. (2026). From Germline Immortality to Somatic Rejuvenation: Unlocking the Ovarian Blueprint for Longevity. PLOS Biology, 24(5), e3003804.

Shuster, L. T., et al. (2010). Premature Menopause or Early Menopause: Long-Term Health Consequences. Maturitas, 65(2), 161–166.

Lumsden, M. A., et al. (2025). European Society of Endocrinology Clinical Practice Guideline for Evaluation and Management of Menopause and the Perimenopause. European Journal of Endocrinology, 193(4), G49–G81.

Rossouw, J. E., et al. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321–333.

Hodis, H. N., & Mack, W. J. (2014). Hormone Replacement Therapy and the Association with Coronary Heart Disease and Overall Mortality: Clinical Application of the Timing Hypothesis. The Journal of Steroid Biochemistry and Molecular Biology, 142, 68–75.

Stuenkel, C. A., et al. (2015). Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011.

Chester, R. C., Kling, J. M., & Manson, J. E. (2018). What the Women’s Health Initiative Has Taught Us About Menopausal Hormone Therapy. Clinical Cardiology, 41(2), 247–252.

The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause, 29(7), 767–794.

U.S. Food and Drug Administration. (2026, February 12). FDA Approves Labeling Changes to Menopausal Hormone Therapy Products.

Brent, L. J. N., et al. (2015). Ecological Knowledge, Leadership, and the Evolution of Menopause in Killer Whales. Current Biology, 25(6), 746–750.

Croft, D. P., et al. (2017). Reproductive Conflict and the Evolution of Menopause in Killer Whales. Current Biology, 27(2), 298–304.

Ellis, S., et al. (2024). The Evolution of Menopause in Toothed Whales. Nature, 627, 579–585.

Gammill, H. S., & Nelson, J. L. (2010). Naturally Acquired Microchimerism. The International Journal of Developmental Biology, 54, 531–543.

Chan, W. F. N., et al. (2012). Male Microchimerism in the Human Female Brain. PLOS ONE, 7(9), e45592.

Mahmood, U., & O’Donoghue, K. (2014). Microchimeric Fetal Cells Play a Role in Maternal Wound Healing After Pregnancy. Chimerism, 5(2), 40–52.

Boddy, A. M., et al. (2015). Fetal Microchimerism and Maternal Health. BioEssays, 37(10), 1106–1118.

Travison, T. G., et al. (2007). A Population-Level Decline in Serum Testosterone Levels in American Men. The Journal of Clinical Endocrinology & Metabolism, 92(1), 196–202.

Wu, F. C. W., et al. (2010). Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. The New England Journal of Medicine, 363(2), 123–135.

Muraleedharan, V., & Jones, T. H. (2010). Testosterone and the Metabolic Syndrome. Therapeutic Advances in Endocrinology and Metabolism, 1(5), 207–223.

Bhasin, S., et al. (2018). Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744.

Hudson, J., et al. (2022). Adverse Cardiovascular Events and Mortality in Men During Testosterone Treatment: An Individual Patient and Aggregate Data Meta-Analysis. The Lancet Healthy Longevity, 3(6), e381–e393.

Lincoff, A. M., et al. (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. The New England Journal of Medicine, 389(2), 107–117.

Snyder, P. J., et al. (2024). Testosterone Treatment and Fractures in Men with Hypogonadism. The New England Journal of Medicine, 390(3), 203–211.

U.S. Food and Drug Administration. (2025, February 28). FDA Issues Class-Wide Labeling Changes for Testosterone Products.

Endocrine Society. (2026, July 16). Statement on Testosterone Replacement Therapy.

Homérosz. Odüsszeia. Fordította Devecseri Gábor. Több magyar kiadásban.

Michie, S., van Stralen, M. M., & West, R. (2011). The Behaviour Change Wheel: A New Method for Characterising and Designing Behaviour Change Interventions. Implementation Science, 6, 42.

Radácsi, L. (2024). Gondolkodj okosan! Az intellektuális szupererő. Budapest: MCC Press.

Ineichen, B. V., Furrer, E., Grüninger, S. L., Zürrer, W. E., & Macleod, M. R. (2024). Analysis of Animal-to-Human Translation Shows That Only 5% of Animal-Tested Therapeutic Interventions Obtain Regulatory Approval for Human Applications. PLOS Biology, 22(6), e3002667.

U.S. Food and Drug Administration. (2024). Questions and Answers on Dietary Supplements.

National Center for Complementary and Integrative Health. (2024). Using Dietary Supplements Wisely.

Fogg, B. J. (2009). A Behavior Model for Persuasive Design. In Persuasive ’09: Proceedings of the 4th International Conference on Persuasive Technology, Article 40, 1–7.

Fogg, B. J. (2019). Tiny Habits: The Small Changes That Change Everything. Houghton Mifflin Harcourt.

Gollwitzer, P. M. (1999). Implementation Intentions: Strong Effects of Simple Plans. American Psychologist, 54(7), 493–503.

Gollwitzer, P. M., & Sheeran, P. (2006). Implementation Intentions and Goal Achievement: A Meta-Analysis of Effects and Processes. Advances in Experimental Social Psychology, 38, 69–119.

Lally, P., van Jaarsveld, C. H. M., Potts, H. W. W., & Wardle, J. (2010). How Are Habits Formed: Modelling Habit Formation in the Real World. European Journal of Social Psychology, 40(6), 998–1009.

Gardner, B. (2015). A Review and Analysis of the Use of ‘Habit’ in Understanding, Predicting and Influencing Health-Related Behaviour. Health Psychology Review, 9(3), 277–295.

Wood, W., & Rünger, D. (2016). Psychology of Habit. Annual Review of Psychology, 67, 289–314.

Thaler, R. H., & Sunstein, C. R. (2008). Nudge: Improving Decisions About Health, Wealth, and Happiness. Yale University Press.

Mertens, S., Herberz, M., Hahnel, U. J. J., & Brosch, T. (2022). The Effectiveness of Nudging: A Meta-Analysis of Choice Architecture Interventions Across Behavioral Domains. Proceedings of the National Academy of Sciences, 119(1), e2107346118.

Maier, M., Bartoš, F., Stanley, T. D., Shanks, D. R., Harris, A. J. L., & Wagenmakers, E.-J. (2022). No Evidence for Nudging After Adjusting for Publication Bias. Proceedings of the National Academy of Sciences, 119(31), e2200300119.

Laibson, D. (1997). Golden Eggs and Hyperbolic Discounting. The Quarterly Journal of Economics, 112(2), 443–477.

Ainslie, G. (2001). Breakdown of Will. Cambridge University Press.

Milkman, K. L., Minson, J. A., & Volpp, K. G. M. (2014). Holding the Hunger Games Hostage at the Gym: An Evaluation of Temptation Bundling. Management Science, 60(2), 283–299.

Ersner-Hershfield, H., Wimmer, G. E., & Knutson, B. (2009). Saving for the Future Self: Neural Measures of Future Self-Continuity Predict Temporal Discounting. Social Cognitive and Affective Neuroscience, 4(1), 85–92.

Hershfield, H. E. (2011). Future Self-Continuity: How Conceptions of the Future Self Transform Intertemporal Choice. Annals of the New York Academy of Sciences, 1235(1), 30–43.

Harkin, B., Webb, T. L., Chang, B. P. I., Prestwich, A., Conner, M., Kellar, I., Benn, Y., & Sheeran, P. (2016). Does Monitoring Goal Progress Promote Goal Attainment? A Meta-Analysis of the Experimental Evidence. Psychological Bulletin, 142(2), 198–229.

Christakis, N. A., & Fowler, J. H. (2007). The Spread of Obesity in a Large Social Network over 32 Years. The New England Journal of Medicine, 357(4), 370–379.

Shalizi, C. R., & Thomas, A. C. (2011). Homophily and Contagion Are Generically Confounded in Observational Social Network Studies. Sociological Methods & Research, 40(2), 211–239.

Christakis, N. A., & Fowler, J. H. (2013). Social Contagion Theory: Examining Dynamic Social Networks and Human Behavior. Statistics in Medicine, 32(4), 556–577.

Aral, S., & Nicolaides, C. (2017). Exercise Contagion in a Global Social Network. Nature Communications, 8, 14753.

Prak, M. (2011). Mega-Structures of the Middle Ages: The Construction of Religious Buildings in Europe and Asia, c. 1000–1500. Journal of Global History, 6(3), 381–406.

Krznaric, R. (2020). The Good Ancestor: A Radical Prescription for Long-Term Thinking. The Experiment.

Pausanias. Description of Greece, 1.23.4.

Oxford Classical Dictionary. (2016). Hygieia. In The Oxford Classical Dictionary. Oxford University Press.

OECD & European Observatory on Health Systems and Policies. (2025). Hungary: Country Health Profile 2025. State of Health in the EU. OECD Publishing.

World Health Organization Commission on Social Determinants of Health. (2008). Closing the Gap in a Generation. World Health Organization.

Belügyminisztérium – Egészségügyi Államtitkárság, Egészségügyi Szakmai Kollégium. (2023). Egészségügyi szakmai irányelv – A praxisközösségekben végzett, felnőtteket érintő prevenciós rendelésről. Azonosító: 002138.

SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. (2021). SCORE2 Risk Prediction Algorithms: New Models to Estimate 10-Year Risk of Cardiovascular Disease in Europe. European Heart Journal, 42(25), 2439–2454.

SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration. (2021). SCORE2-OP Risk Prediction Algorithms: Estimating Incident Cardiovascular Event Risk in Older Persons in Four Geographical Risk Regions. European Heart Journal, 42(25), 2455–2467.

McEvoy, J. W., et al. (2024). 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension. European Heart Journal, 45(38), 3912–4018.

Mach, F., et al. (2025). 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal, 46(42), 4359–4378.

Kronenberg, F., et al. (2022). Lipoprotein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement. European Heart Journal, 43(39), 3925–3946.

Jermendy, G., et al. (2023). A diabetes mellitus kórismézéséről, a cukorbetegek antihyperglykaemiás kezeléséről és gondozásáról felnőttkorban. Diabetologia Hungarica, 31(5), 331–444.

American Diabetes Association Professional Practice Committee. (2026). Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement 1), S27–S49.

Diabetes Prevention Program Research Group. (2002). Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The New England Journal of Medicine, 346(6), 393–403.

Richardson, K. M., et al. (2024). The Efficacy of Using Continuous Glucose Monitoring as a Behaviour Change Tool in Populations with and without Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. International Journal of Behavioral Nutrition and Physical Activity, 21, 145.

Belügyminisztérium – Egészségügyi Államtitkárság, Egészségügyi Szakmai Kollégium. (2023). Egészségügyi szakmai irányelv – A felnőttkori elhízás diagnosztikájáról és kezeléséről. Azonosító: 002240.

Kapur, V. K., et al. (2017). Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine, 13(3), 479–504.

Patil, S. P., et al. (2019). Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine, 15(2), 335–343.

Ramar, K., et al. (2015). Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. Journal of Clinical Sleep Medicine, 11(7), 773–827.

Belügyminisztérium – Egészségügyi Államtitkárság, Egészségügyi Szakmai Kollégium. (2024). Egészségügyi szakmai irányelv – A dohányzásról való leszokás támogatásáról. Azonosító: 002218.

World Health Organization. (2024). WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. WHO.

World Health Organization Regional Office for Europe. (2025). Alcohol and Cancer. WHO Regional Office for Europe.

Nemzeti Népegészségügyi és Gyógyszerészeti Központ. (2025). Az NNGYK módszertani levele a 2025. évi védőoltásokról.

Nemzeti Népegészségügyi és Gyógyszerészeti Központ. (é. n.). Felnőttkori védőoltások ütemezésének ajánlása. Hozzáférés: 2026. augusztus 6.

Hou, Y., et al. (2024). Insights into Vaccines for Elderly Individuals: From the Impacts of Immunosenescence to Delivery Strategies. npj Vaccines, 9, 77.

Wilson, J. M. G., & Jungner, G. (1968). Principles and Practice of Screening for Disease. World Health Organization.

Ahn, H. S., Kim, H. J., & Welch, H. G. (2014). Korea’s Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis. The New England Journal of Medicine, 371(19), 1765–1767.

World Health Organization Regional Office for Europe. (2020). Screening Programmes: A Short Guide. Increase Effectiveness, Maximize Benefits and Minimize Harm. WHO Regional Office for Europe.

World Health Organization Regional Office for Europe. (2022). A Short Guide to Cancer Screening: Increase Effectiveness, Maximize Benefits and Minimize Harm. WHO Regional Office for Europe.

Council of the European Union. (2022). Council Recommendation on Strengthening Prevention Through Early Detection: A New EU Approach on Cancer Screening. Official Journal of the European Union.

Nemzeti Népegészségügyi és Gyógyszerészeti Központ. (é. n.). Tudnivalók az emlőszűrésről. Hozzáférés: 2026. augusztus 6.

Nemzeti Népegészségügyi és Gyógyszerészeti Központ. (é. n.). Tudnivalók a méhnyakszűrésről. Hozzáférés: 2026. augusztus 6.

Nemzeti Népegészségügyi és Gyógyszerészeti Központ. (é. n.). Tudnivalók a vastagbélszűrésről. Hozzáférés: 2026. augusztus 6.

Belügyminisztérium – Egészségügyi Államtitkárság, Egészségügyi Szakmai Kollégium. (2025). Egészségügyi szakmai irányelv – A prosztatarák komplex diagnosztikájáról és ellátásáról. Azonosító: 002241.

Egészségvonal. (2025). Tüdőszűrés – Országos Tüdőrákszűrő Program és alacsony dózisú CT. Módosítás: 2025. december 3.

Welch, H. G., & Black, W. C. (2010). Overdiagnosis in Cancer. Journal of the National Cancer Institute, 102(9), 605–613.

Klein, E. A., et al. (2021). Clinical Validation of a Targeted Methylation-Based Multi-Cancer Early Detection Test Using an Independent Validation Set. Annals of Oncology, 32(9), 1167–1177.

Hoffman, R. M., et al. (2025). Multicancer Early Detection Testing: Guidance for Primary Care Discussions with Patients. Cancer, 131(7), e35823.

National Cancer Institute. (2025). The Vanguard Study on Multi-Cancer Detection Tests. Cancer Screening Research Network.

American College of Radiology. (2023). ACR Statement on Screening Total Body MRI.

Kwee, R. M., & Kwee, T. C. (2019). Whole-Body MRI for Preventive Health Screening: A Systematic Review of the Literature. Journal of Magnetic Resonance Imaging, 50(5), 1489–1503.

World Health Organization. (2025). Integrated Care for Older People – ICOPE: Guidance for Person-Centred Assessment and Pathways in Primary Care. Second edition. WHO.

Belügyminisztérium – Egészségügyi Államtitkárság, Egészségügyi Szakmai Kollégium. (2025a). Egészségügyi szakmai irányelv – A multimorbid geriátriai betegek ellátásáról és kezeléséről. Azonosító: 002278.

Belügyminisztérium – Egészségügyi Államtitkárság, Egészségügyi Szakmai Kollégium. (2025b). Egészségügyi szakmai irányelv – A geriátriai re-adaptációról a multimorbid idős betegek önellátó képességének javítására. Azonosító: 002279.

Montero-Odasso, M., et al. (2022). World Guidelines for Falls Prevention and Management for Older Adults: A Global Initiative. Age and Ageing, 51(9), afac205.

Kanis, J. A., et al. (2019). European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women. Osteoporosis International, 30, 3–44.

Hajishengallis, G. (2015). Periodontitis: From Microbial Immune Subversion to Systemic Inflammation. Nature Reviews Immunology, 15(1), 30–44.

Livingston, G., et al. (2024). Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission. The Lancet, 404, 572–628.

Marmot, M., et al. (2020). Health Equity in England: The Marmot Review 10 Years On. Institute of Health Equity.

World Health Organization. (2020). Decade of Healthy Ageing: Baseline Report. WHO.

Vyāsa. The Mahabharata of Krishna-Dwaipayana Vyasa. Book 1: Adi Parva, Sections 15–18. Trans. K. M. Ganguli. P. C. Roy, 1883–1896.

Kirkwood, T. B. L. (1977). Evolution of Ageing. Nature, 270, 301–304.

Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012). AMPK: A Nutrient and Energy Sensor That Maintains Energy Homeostasis. Nature Reviews Molecular Cell Biology, 13, 251–262.

Laplante, M., & Sabatini, D. M. (2012). mTOR Signaling in Growth Control and Disease. Cell, 149(2), 274–293.

Fontana, L., Partridge, L., & Longo, V. D. (2010). Extending Healthy Life Span—From Yeast to Humans. Science, 328(5976), 321–326.

Saxton, R. A., & Sabatini, D. M. (2017). mTOR Signaling in Growth, Metabolism, and Disease. Cell, 168(6), 960–976.

Vézina, C., Kudelski, A., & Sehgal, S. N. (1975). Rapamycin (AY-22,989), a New Antifungal Antibiotic. I. Taxonomy of the Producing Streptomycete and Isolation of the Active Principle. Journal of Antibiotics, 28(10), 721–726.

Hatori, M., et al. (2012). Time-Restricted Feeding Without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet. Cell Metabolism, 15(6), 848–860.

Sutton, E. F., et al. (2018). Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even Without Weight Loss in Men with Prediabetes. Cell Metabolism, 27(6), 1212–1221.e3.

Anton, S. D., et al. (2018). Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity, 26(2), 254–268.

Kraus, W. E., et al. (2019). Two Years of Calorie Restriction and Cardiometabolic Risk: Exploratory Outcomes of a Multicentre, Phase 2, Randomised Controlled Trial. The Lancet Diabetes & Endocrinology, 7(9), 673–683.

Iiams, S. E., Skinner, N. J., Green, C. B., & Takahashi, J. S. (2026). Circadian Alignment Through Time-Restricted Feeding: Implications for Health and Longevity. Annual Review of Nutrition. Advance online publication. https://doi.org/10.1146/annurev-nutr-112525-011241.

Svendsen, M., & Forslund, H. B. (2023). Meal Patterns, Including Intermittent Fasting. In Nordic Nutrition Recommendations 2023. Copenhagen: Nordic Council of Ministers.

Shimazu, T., et al. (2013). Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor. Science, 339(6116), 211–214.

Paoli, A., et al. (2013). Beyond Weight Loss: A Review of the Therapeutic Uses of Very-Low-Carbohydrate Ketogenic Diets. European Journal of Clinical Nutrition, 67, 789–796.

Kossoff, E. H., et al. (2018). Optimal Clinical Management of Children Receiving Dietary Therapies for Epilepsy: Updated Recommendations of the International Ketogenic Diet Study Group. Epilepsia Open, 3(2), 175–192.

Goodpaster, B. H., & Sparks, L. M. (2017). Metabolic Flexibility in Health and Disease. Cell Metabolism, 25(5), 1027–1036.

Howitz, K. T., & Sinclair, D. A. (2008). Xenohormesis: Sensing the Chemical Cues of Other Species. Cell, 133(3), 387–391.

Baur, J. A., & Sinclair, D. A. (2006). Therapeutic Potential of Resveratrol: The In Vivo Evidence. Nature Reviews Drug Discovery, 5, 493–506.

Brownlee, M. (2001). Biochemistry and Molecular Cell Biology of Diabetic Complications. Nature, 414, 813–820.

Vlassara, H., & Uribarri, J. (2014). Advanced Glycation End Products and Diabetes Complications: Cause, Effect, or Both? Current Diabetes Reports, 14, 453.

Bannister, C. A., et al. (2014). Can People with Type 2 Diabetes Live Longer Than Those Without? A Comparison of Mortality in People Initiated with Metformin or Sulphonylurea Monotherapy and Matched, Non-Diabetic Controls. Diabetes, Obesity and Metabolism, 16(11), 1165–1173.

Hur, K. Y., & Lee, M. S. (2015). New Mechanisms of Metformin Action: Focusing on Mitochondria and the Gut. Journal of Diabetes Investigation, 6(6), 600–609.

Barzilai, N., et al. (2016). Metformin as a Tool to Target Aging. Cell Metabolism, 23(6), 1060–1065.

American Federation for Aging Research. (2026). TAME – Targeting Aging with Metformin. Official program page, accessed 6 August 2026.

Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine, 387, 205–216.

Lincoff, A. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes. The New England Journal of Medicine, 389, 2221–2232.

Malhotra, A., et al. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. The New England Journal of Medicine, 391, 1193–1205.

Zhao, L., et al. (2024). Tirzepatide for Weight Reduction in Chinese Adults with Obesity: The SURMOUNT-CN Randomized Clinical Trial. JAMA, 332(7), 551–560.

U.S. Food and Drug Administration. (2024). FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight. 8 March 2024.

U.S. Food and Drug Administration. (2024). FDA Approves First Medication for Obstructive Sleep Apnea. 20 December 2024.

Volpi, E., et al. (2003). Essential Amino Acids Are Primarily Responsible for the Amino Acid Stimulation of Muscle Protein Anabolism in Healthy Elderly Adults. The American Journal of Clinical Nutrition, 78(2), 250–258.

Paddon-Jones, D., & Rasmussen, B. B. (2009). Dietary Protein Recommendations and the Prevention of Sarcopenia. Current Opinion in Clinical Nutrition and Metabolic Care, 12(1), 86–90.

Bauer, J., et al. (2013). Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association, 14(8), 542–559.

Deutz, N. E. P., et al. (2014). Protein Intake and Exercise for Optimal Muscle Function with Aging: Recommendations from the ESPEN Expert Group. Clinical Nutrition, 33(6), 929–936.

Mamerow, M. M., et al. (2014). Dietary Protein Distribution Positively Influences 24-h Muscle Protein Synthesis in Healthy Adults. The Journal of Nutrition, 144(6), 876–880.

Moore, D. R., et al. (2015). Protein Ingestion to Stimulate Myofibrillar Protein Synthesis Requires Greater Relative Protein Intakes in Healthy Older Versus Younger Men. The Journals of Gerontology: Series A, 70(1), 57–62.

Schoenfeld, B. J., et al. (2015). Effects of meal frequency on weight loss and body composition: A meta-analysis. Nutrition Reviews, 73(2), 69–82.

Harris, S., DePalma, J., & Barkoukis, H. (2025). Protein and Aging: Practicalities and Practice. Nutrients, 17(15), 2461. https://doi.org/10.3390/nu17152461.

Orentreich, N., et al. (1993). Low Methionine Ingestion by Rats Extends Life Span. The Journal of Nutrition, 123(2), 269–274.

Lee, B. C., Kaya, A., & Gladyshev, V. N. (2016). Methionine Restriction and Life-Span Control. Annals of the New York Academy of Sciences, 1363, 116–124.

Miller, R. A., et al. (2019). Glycine Supplementation Extends Lifespan of Male and Female Mice. Aging Cell, 18(3), e12953.

Camacho-Pereira, J., et al. (2016). CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction Through an SIRT3-Dependent Mechanism. Cell Metabolism, 23(6), 1127–1139.

Dellinger, R. W., et al. (2017). Repeat Dose NRPT Increases NAD⁺ Levels in Humans Safely and Sustainably: A Randomized, Double-Blind, Placebo-Controlled Study. npj Aging and Mechanisms of Disease, 3, 17.

Yoshino, J., Baur, J. A., & Imai, S.-I. (2018). NAD⁺ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513–528.

Martens, C. R., et al. (2018). Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD⁺ in Healthy Middle-Aged and Older Adults. Nature Communications, 9, 1286.

Dollerup, O. L., et al. (2018). A Randomized Placebo-Controlled Clinical Trial of Nicotinamide Riboside in Obese Men: Safety, Insulin Sensitivity, and Lipid-Mobilizing Effects. The American Journal of Clinical Nutrition, 108(2), 343–353.

McReynolds, M. R., Chellappa, K., & Baur, J. A. (2020). Age-Related NAD⁺ Decline. Experimental Gerontology, 134, 110888.

Covarrubias, A. J., et al. (2021). NAD⁺ Metabolism and Its Roles in Cellular Processes During Ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141.

Damgaard, M. V., & Treebak, J. T. (2023). What Is Really Known About the Effects of Nicotinamide Riboside Supplementation in Humans? Science Advances, 9(29), eadi4862.

Freeberg, K. A., et al. (2023). Dietary Supplementation with NAD⁺-Boosting Compounds in Humans: Current Knowledge and Future Directions. The Journals of Gerontology: Series A, 78(12), 2435–2448.

Harris, C. B., et al. (2013). The Effect of Dietary Pyrroloquinoline Quinone on Indicators of Inflammation and Mitochondrial-Related Metabolism in Human Subjects. The Journal of Nutritional Biochemistry, 24(12), 2076–2084.

Eisenberg, T., et al. (2016). Cardioprotection and Lifespan Extension by the Natural Polyamine Spermidine. Nature Medicine, 22, 1428–1438.

Madeo, F., et al. (2018). Spermidine in Health and Disease. Science, 359(6374), eaan2788.

Wirth, M., et al. (2022). Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults with Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Network Open, 5(5), e2213875.

Numaguchi, T., et al. (2026). Dietary Pyrroloquinoline Quinone and Spermidine in Healthy Longevity: Targeting the Hallmarks of Aging. Frontiers in Aging, 7, 1791853.

Ryu, D., Mouchiroud, L., Andreux, P. A., et al. (2016). Urolithin A Induces Mitophagy and Prolongs Lifespan in C. elegans and Increases Muscle Function in Rodents. Nature Medicine, 22(8), 879–888. doi:10.1038/nm.4132.

Liu, S., D’Amico, D., Shankland, E., et al. (2022). Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open, 5(1), e2144279. doi:10.1001/jamanetworkopen.2021.44279.

Yousefzadeh, M. J., Zhu, Y., McGowan, S. J., et al. (2018). Fisetin Is a Senotherapeutic That Extends Health and Lifespan. EBioMedicine, 36, 18–28. doi:10.1016/j.ebiom.2018.09.015.

Lee, E., & Burns, M. (2024). The Effects of Fisetin on Reducing Biological Aging: A Pilot Study. Alternative Therapies in Health and Medicine, 30(9), 6–10.

Singh, P., Gollapalli, K., Mangiola, S., et al. (2023). Taurine Deficiency as a Driver of Aging. Science, 380(6649), eabn9257. doi:10.1126/science.abn9257.

Fernandez, M. E., Bernier, M., Price, N. L., et al. (2025). Is Taurine an Aging Biomarker? Science, 388(6751), eadl2116. doi:10.1126/science.adl2116.

Denk, D., Singh, A., Kasler, H. G., et al. (2025). Effect of the Mitophagy Inducer Urolithin A on Age-Related Immune Decline: A Randomized, Placebo-Controlled Trial. Nature Aging, 5, 2309–2322. doi:10.1038/s43587-025-00996-x.

Szűcs, Zs. (2016). OKOSTÁNYÉR® – Új táplálkozási ajánlás a hazai felnőtt lakosság számára. Új Diéta, 25(2–3), 20–23.

Magyar Dietetikusok Országos Szövetsége. (2021). OKOSTÁNYÉR® – Felnőtteknek. Megújított hazai táplálkozási ajánlás.

Nordic Council of Ministers. (2023). Nordic Nutrition Recommendations 2023. Copenhagen: Nordic Council of Ministers.

Food and Agriculture Organization of the United Nations & World Health Organization. (2024). What Are Healthy Diets? Joint Statement.

World Health Organization. (2026). Healthy Diet. Fact sheet, updated 26 January 2026.

Homéroszi himnuszok. Démétérhez. Magyar fordítás: Devecseri Gábor. Több magyar kiadásban.

Metchnikoff, É. (1907). The Prolongation of Life: Optimistic Studies. G. P. Putnam’s Sons.

Human Microbiome Project Consortium. (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207–214. doi:10.1038/nature11234

Qin, J., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285), 59–65. doi:10.1038/nature08821

Bordenstein, S. R., & Theis, K. R. (2015). Host biology in light of the microbiome: Ten principles of holobionts and hologenomes. PLOS Biology, 13(8), e1002226. doi:10.1371/journal.pbio.1002226

Douglas, A. E., & Werren, J. H. (2016). Holes in the hologenome: Why host–microbe symbioses are not holobionts. mBio, 7(2), e02099-15. doi:10.1128/mBio.02099-15

Sender, R., Fuchs, S., & Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLOS Biology, 14(8), e1002533. doi:10.1371/journal.pbio.1002533

Borrel, G., Brugère, J.-F., Gribaldo, S., Schmitz, R. A., & Moissl-Eichinger, C. (2020). The host-associated archaeome. Nature Reviews Microbiology, 18(11), 622–636. doi:10.1038/s41579-020-0407-y

Claesson, M. J., et al. (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature, 488(7410), 178–184. doi:10.1038/nature11319

Biagi, E., et al. (2016). Gut microbiota and extreme longevity. Current Biology, 26(11), 1480–1485. doi:10.1016/j.cub.2016.04.016

Sato, Y., et al. (2021). Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature, 599(7885), 458–464. doi:10.1038/s41586-021-03832-5

Shkoporov, A. N., & Hill, C. (2019). Bacteriophages of the human gut: The “known unknown” of the microbiome. Cell Host & Microbe, 25(2), 195–209. doi:10.1016/j.chom.2019.01.017

Nash, A. K., et al. (2017). The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome, 5, 153. doi:10.1186/s40168-017-0373-4

Dedrick, R. M., et al. (2019). Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nature Medicine, 25(5), 730–733. doi:10.1038/s41591-019-0437-z

Camilleri, M. (2019). Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut, 68(8), 1516–1526. doi:10.1136/gutjnl-2019-318427

Thevaranjan, N., et al. (2017). Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host & Microbe, 21(4), 455–466.e4. doi:10.1016/j.chom.2017.03.002

Desai, M. S., et al. (2016). A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell, 167(5), 1339–1353.e21. doi:10.1016/j.cell.2016.10.043

Sonnenburg, E. D., et al. (2016). Diet-induced extinctions in the gut microbiota compound over generations. Nature, 529(7585), 212–215. doi:10.1038/nature16504

Donohoe, D. R., et al. (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism, 13(5), 517–526. doi:10.1016/j.cmet.2011.02.018

Aanen, D. K., et al. (2002). The evolution of fungus-growing termites and their mutualistic fungal symbionts. Proceedings of the National Academy of Sciences, 99(23), 14887–14892. doi:10.1073/pnas.222313099

Chassaing, B., et al. (2015). Dietary Emulsifiers Impact the Mouse Gut Microbiota Promoting Colitis and Metabolic Syndrome. Nature, 519, 92–96.

Hall, K. D., et al. (2019). Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake. Cell Metabolism, 30(1), 67–77.e3.

Chassaing, B., et al. (2022). Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome. Gastroenterology, 162(3), 743–756.

Wellens, J., et al. (2026). Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-Controlled Randomized Trial. Clinical Gastroenterology and Hepatology, 24(4), 1092–1101. https://doi.org/10.1016/j.cgh.2025.08.005.

Cryan, J. F., et al. (2019). The microbiota–gut–brain axis. Physiological Reviews, 99(4), 1877–2013. doi:10.1152/physrev.00018.2018

Yano, J. M., et al. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264–276. doi:10.1016/j.cell.2015.02.047

Braak, H., et al. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24(2), 197–211. doi:10.1016/S0197-4580(02)00065-9

Horsager, J., et al. (2020). Brain-first versus body-first Parkinson’s disease: A multimodal imaging case-control study. Brain, 143(10), 3077–3088. doi:10.1093/brain/awaa238

Suganya, K., & Koo, B.-S. (2020). Gut–brain axis: Role of gut microbiota on neurological disorders and how probiotics and prebiotics beneficially modulate microbial and immune pathways. International Journal of Molecular Sciences, 21(20), 7551. doi:10.3390/ijms21207551

Hill, C., et al. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. doi:10.1038/nrgastro.2014.66

Suez, J., et al. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 174(6), 1406–1423.e16. doi:10.1016/j.cell.2018.08.047

Gibson, G. R., et al. (2017). The International Scientific Association for Probiotics and Prebiotics consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14(8), 491–502. doi:10.1038/nrgastro.2017.75

Marco, M. L., et al. (2021). The International Scientific Association for Probiotics and Prebiotics consensus statement on fermented foods. Nature Reviews Gastroenterology & Hepatology, 18(3), 196–208. doi:10.1038/s41575-020-00390-5

Salminen, S., et al. (2021). The International Scientific Association of Probiotics and Prebiotics consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology, 18(9), 649–667. doi:10.1038/s41575-021-00440-6

Wastyk, H. C., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137–4153.e14. doi:10.1016/j.cell.2021.06.019

Goodman, C., Keating, G., Georgousopoulou, E., Hespe, C., & Levett, K. (2021). Probiotics for the prevention of antibiotic-associated diarrhoea: A systematic review and meta-analysis. BMJ Open, 11(8), e043054. doi:10.1136/bmjopen-2020-043054

Dethlefsen, L., & Relman, D. A. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proceedings of the National Academy of Sciences, 108(Suppl. 1), 4554–4561. doi:10.1073/pnas.1000087107

World Health Organization. (2026). Antimicrobial resistance. Fact sheet, updated 16 July 2026. Geneva: World Health Organization.

Allen, J. M., et al. (2018). Exercise alters gut microbiota composition and function in lean and obese humans. Medicine & Science in Sports & Exercise, 50(4), 747–757. doi:10.1249/MSS.0000000000001495

Thaiss, C. A., et al. (2014). Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell, 159(3), 514–529. doi:10.1016/j.cell.2014.09.048

Vich Vila, A., et al. (2020). Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nature Communications, 11, 362. doi:10.1038/s41467-019-14177-z

Boehme, M., et al. (2021). Microbiota from young mice counteracts selective age-associated behavioral deficits. Nature Aging, 1(8), 666–676. doi:10.1038/s43587-021-00093-9

Parker, A., et al. (2022). Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome, 10, 68. doi:10.1186/s40168-022-01243-w

Peery, A. F., et al. (2024). AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology, 166(3), 409–434. doi:10.1053/j.gastro.2024.01.008

Belügyminisztérium. (2025). Egészségügyi szakmai irányelv a hagyományos intesztinális mikrobióta transzplantációs eljárás kivitelezéséről. Egészségügyi Közlöny, 75(14), 1656–1687. Hivatalos oldal

U.S. Food and Drug Administration. (2019). Fecal microbiota for transplantation: Safety communication—risk of serious adverse reactions due to transmission of multi-drug resistant organisms. Hivatalos oldal

U.S. Food and Drug Administration. (2020). Safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms. Hivatalos oldal

U.S. Food and Drug Administration. (2022). Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridioides difficile infection not responsive to standard therapies: Guidance for industry. Hivatalos oldal

U.S. Food and Drug Administration. (2022). REBYOTA (fecal microbiota, live-jslm): Product information. Hivatalos oldal

U.S. Food and Drug Administration. (2023). VOWST (fecal microbiota spores, live-brpk): Product information. Hivatalos oldal

ClinicalTrials.gov. (2026). Effect of gut microbiome intervention on aging via oral FMT (STEP-aging). NCT05598112. Rekord megtekintve: 2026. augusztus 6.; eredmény nem volt feltöltve, a státusz több mint két éve nem volt megerősítve. Vizsgálati rekord

Porcari, S., et al. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154–167. doi:10.1016/S2468-1253(24)00311-X

Hésziodosz. Theogonia.

Hésziodosz. Munkák és napok.

Aiszkhülosz. Prométheusz megláncolva.

Holloszy, J. O. (1967). Biochemical Adaptations in Muscle: Effects of Exercise on Mitochondrial Oxygen Uptake and Respiratory Enzyme Activity in Skeletal Muscle. Journal of Biological Chemistry, 242(9), 2278–2282. https://doi.org/10.1016/S0021-9258(18)96046-1

Coffey, V. G., & Hawley, J. A. (2007). The Molecular Bases of Training Adaptation. Sports Medicine, 37(9), 737–763. https://doi.org/10.2165/00007256-200737090-00001

Handschin, C., & Spiegelman, B. M. (2008). The Role of Exercise and PGC-1α in Inflammation and Chronic Disease. Nature, 454(7203), 463–469. https://doi.org/10.1038/nature07206

Radák, Z., Chung, H. Y., Koltai, E., Taylor, A. W., & Goto, S. (2008). Exercise, Oxidative Stress and Hormesis. Ageing Research Reviews, 7(1), 34–42. https://doi.org/10.1016/j.arr.2007.04.004

Radák, Z., Zhao, Z., Koltai, E., Ohno, H., & Atalay, M. (2013). Oxygen Consumption and Usage During Physical Exercise: The Balance Between Oxidative Stress and ROS-Dependent Adaptive Signaling. Antioxidants & Redox Signaling, 18(10), 1208–1246. https://doi.org/10.1089/ars.2011.4498

Egan, B., & Zierath, J. R. (2013). Exercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation. Cell Metabolism, 17(2), 162–184. https://doi.org/10.1016/j.cmet.2012.12.012

Pedersen, B. K., & Febbraio, M. A. (2008). Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6. Physiological Reviews, 88(4), 1379–1406. https://doi.org/10.1152/physrev.90100.2007

Pedersen, B. K., & Febbraio, M. A. (2012). Muscles, Exercise and Obesity: Skeletal Muscle as a Secretory Organ. Nature Reviews Endocrinology, 8(8), 457–465. https://doi.org/10.1038/nrendo.2012.49

Brooks, G. A. (2018). The Science and Translation of Lactate Shuttle Theory. Cell Metabolism, 27(4), 757–785. https://doi.org/10.1016/j.cmet.2018.03.008

Fox, F. A. U., et al. (2023). Physical Activity Is Associated With Slower Epigenetic Ageing—Findings From the Rhineland Study. Aging Cell, 22(6), e13828. https://doi.org/10.1111/acel.13828

Erickson, K. I., et al. (2011). Exercise Training Increases Size of Hippocampus and Improves Memory. Proceedings of the National Academy of Sciences, 108(7), 3017–3022. https://doi.org/10.1073/pnas.1015950108

Issurin, V. B. (2010). New Horizons for the Methodology and Physiology of Training Periodization. Sports Medicine, 40(3), 189–206. https://doi.org/10.2165/11319770-000000000-00000

Meeusen, R., et al. (2013). Prevention, Diagnosis, and Treatment of the Overtraining Syndrome: Joint Consensus Statement of the European College of Sport Science and the American College of Sports Medicine. Medicine & Science in Sports & Exercise, 45(1), 186–205. https://doi.org/10.1249/MSS.0b013e318279a10a

Tremblay, M. S., et al. (2017). Sedentary Behavior Research Network Terminology Consensus Project Process and Outcome. International Journal of Behavioral Nutrition and Physical Activity, 14, 75. https://doi.org/10.1186/s12966-017-0525-8

Dunstan, D. W., et al. (2012). Breaking Up Prolonged Sitting Reduces Postprandial Glucose and Insulin Responses. Diabetes Care, 35(5), 976–983. https://doi.org/10.2337/dc11-1931

Ding, D., et al. (2025). Daily Steps and Health Outcomes in Adults: A Systematic Review and Dose–Response Meta-analysis. The Lancet Public Health, 10(8), e668–e681. https://doi.org/10.1016/S2468-2667(25)00164-1

Stamatakis, E., et al. (2022). Association of Wearable Device-Measured Vigorous Intermittent Lifestyle Physical Activity With Mortality. Nature Medicine, 28(12), 2521–2529. https://doi.org/10.1038/s41591-022-02100-x

Ahmadi, M. N., et al. (2023). Brief Bouts of Device-Measured Intermittent Lifestyle Physical Activity and Its Association With Major Adverse Cardiovascular Events and Mortality in People Who Do Not Exercise. The Lancet Public Health, 8(10), e800–e810. https://doi.org/10.1016/S2468-2667(23)00183-4

World Health Organization. (2020). WHO Guidelines on Physical Activity and Sedentary Behaviour. Geneva: World Health Organization.

Bull, F. C., et al. (2020). World Health Organization 2020 Guidelines on Physical Activity and Sedentary Behaviour. British Journal of Sports Medicine, 54(24), 1451–1462. https://doi.org/10.1136/bjsports-2020-102955

Kodama, S., et al. (2009). Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-analysis. JAMA, 301(19), 2024–2035. https://doi.org/10.1001/jama.2009.681

Ross, R., et al. (2016). Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign. Circulation, 134(24), e653–e699. https://doi.org/10.1161/CIR.0000000000000461

Mandsager, K., et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open, 1(6), e183605. https://doi.org/10.1001/jamanetworkopen.2018.3605

Bouaziz, W., et al. (2020). Effect of High-Intensity Interval Training and Continuous Endurance Training on Peak Oxygen Uptake Among Seniors Aged 65 or Older: A Meta-analysis of Randomized Controlled Trials. International Journal of Clinical Practice, 74(6), e13490. https://doi.org/10.1111/ijcp.13490

Martland, R., et al. (2021). High-Intensity Interval Training in Older Adults: A Scoping Review. Sports Medicine - Open, 7, 49. https://doi.org/10.1186/s40798-021-00344-4

Kirk, B., et al. (2024). Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia. Age and Ageing, 53(3), afae052. https://doi.org/10.1093/ageing/afae052

Cruz-Jentoft, A. J., et al. (2019). Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169

Leong, D. P., et al. (2015). Prognostic Value of Grip Strength: Findings From the Prospective Urban Rural Epidemiology Study. The Lancet, 386(9990), 266–273. https://doi.org/10.1016/S0140-6736(14)62000-6

Fiatarone, M. A., et al. (1990). High-Intensity Strength Training in Nonagenarians: Effects on Skeletal Muscle. JAMA, 263(22), 3029–3034. https://doi.org/10.1001/jama.1990.03440220053029

Fragala, M. S., et al. (2019). Resistance Training for Older Adults: Position Statement From the National Strength and Conditioning Association. Journal of Strength and Conditioning Research, 33(8), 2019–2052. https://doi.org/10.1519/JSC.0000000000003230

Currier, B. S., et al. (2026). American College of Sports Medicine Position Stand: Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Medicine & Science in Sports & Exercise, 58(4), 851–872. https://doi.org/10.1249/MSS.0000000000003897

Čretnik, K., Pleša, J., Kozinc, Ž., Löfler, S., & Šarabon, N. (2022). The Effect of Eccentric vs. Traditional Resistance Exercise on Muscle Strength, Body Composition, and Functional Performance in Older Adults: A Systematic Review With Meta-Analysis. Frontiers in Sports and Active Living, 4, 873718. https://doi.org/10.3389/fspor.2022.873718

Watson, S. L., et al. (2018). High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. Journal of Bone and Mineral Research, 33(2), 211–220. https://doi.org/10.1002/jbmr.3284

Li, F., et al. (2018). Effectiveness of a Therapeutic Tai Ji Quan Intervention vs a Multimodal Exercise Intervention to Prevent Falls Among Older Adults at High Risk of Falling: A Randomized Clinical Trial. JAMA Internal Medicine, 178(10), 1301–1310. https://doi.org/10.1001/jamainternmed.2018.3915

Sherrington, C., et al. (2019). Exercise for Preventing Falls in Older People Living in the Community. Cochrane Database of Systematic Reviews, 1, CD012424. https://doi.org/10.1002/14651858.CD012424.pub2

Ercan Yıldız, S., Fidan, O., Gülşen, C., Çolak, E., & Genç, G. A. (2024). Effect of Dual-Task Training on Balance in Older Adults: A Systematic Review and Meta-analysis. Archives of Gerontology and Geriatrics, 121, 105368. https://doi.org/10.1016/j.archger.2024.105368

Khan, M. J., et al. (2025). Effectiveness of Dual-Task Exercise in Improving Balance and Preventing Falls Among Older Adults: Systematic Review With Meta-analysis and Meta-regression. European Geriatric Medicine, 16, 2047–2083. https://doi.org/10.1007/s41999-025-01328-3

Ovidius. Átváltozások. VII. könyv, 159–293. Magyar fordításban több kiadásban.

Waddington, C. H. (1957). The Strategy of the Genes. George Allen & Unwin.

Goldberg, A. D., Allis, C. D., & Bernstein, E. (2007). Epigenetics: A Landscape Takes Shape. Cell, 128(4), 635–638.

Ferrell, J. E. (2012). Bistability, Bifurcations, and Waddington’s Epigenetic Landscape. Current Biology, 22(11), R458–R466.

Yang, J. H., et al. (2023). Loss of Epigenetic Information as a Cause of Mammalian Aging. Cell, 186(2), 305–326.e27.

Timmons, J. A., & Brenner, C. (2024). The Information Theory of Aging Has Not Been Tested. Cell, 187(5), 1101–1102.

Yang, J. H., Hayano, M., Rajman, L. A., & Sinclair, D. A. (2024). Response to: The Information Theory of Aging Has Not Been Tested. Cell, 187(5), 1103–1105.

Bell, C. G., et al. (2019). DNA Methylation Aging Clocks: Challenges and Recommendations. Genome Biology, 20, 249.

Yücel, A. D., & Gladyshev, V. N. (2024). The Long and Winding Road of Reprogramming-Induced Rejuvenation. Nature Communications, 15, 1941.

Takahashi, K., & Yamanaka, S. (2006). Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell, 126(4), 663–676.

Takahashi, K., et al. (2007). Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131(5), 861–872.

Takahashi, K., & Yamanaka, S. (2016). A Decade of Transcription Factor-Mediated Reprogramming to Pluripotency. Nature Reviews Molecular Cell Biology, 17(3), 183–193.

Lapasset, L., et al. (2011). Rejuvenating Senescent and Centenarian Human Cells by Reprogramming through the Pluripotent State. Genes & Development, 25(21), 2248–2253.

Abad, M., et al. (2013). Reprogramming In Vivo Produces Teratomas and iPS Cells with Totipotency Features. Nature, 502, 340–345.

Ohnishi, K., et al. (2014). Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation. Cell, 156(4), 663–677.

Nobel Prize. (2012). The Nobel Prize in Physiology or Medicine 2012: John B. Gurdon and Shinya Yamanaka.

Ocampo, A., et al. (2016). In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell, 167(7), 1719–1733.e12.

Olova, N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2019). Partial Reprogramming Induces a Steady Decline in Epigenetic Age before Loss of Somatic Identity. Aging Cell, 18(1), e12877.

Sarkar, T. J., et al. (2020). Transient Non-Integrative Expression of Nuclear Reprogramming Factors Promotes Multifaceted Amelioration of Aging in Human Cells. Nature Communications, 11, 1545.

Lu, Y., et al. (2020). Reprogramming to Recover Youthful Epigenetic Information and Restore Vision. Nature, 588, 124–129.

Rodríguez-Matellán, A., Alcazar, N., Hernández, F., Serrano, M., & Ávila, J. (2020). In Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice. Stem Cell Reports, 15(5), 1056–1066.

Wang, C., et al. (2021). In Vivo Partial Reprogramming of Myofibers Promotes Muscle Regeneration by Remodeling the Stem Cell Niche. Nature Communications, 12, 3094.

Chondronasiou, D., et al. (2022). Multi-Omic Rejuvenation of Naturally Aged Tissues by a Single Cycle of Transient Reprogramming. Aging Cell, 21(3), e13578.

Gill, D., et al. (2022). Multi-Omic Rejuvenation of Human Cells by Maturation Phase Transient Reprogramming. eLife, 11, e71624.

Browder, K. C., et al. (2022). In Vivo Partial Reprogramming Alters Age-Associated Molecular Changes during Physiological Aging in Mice. Nature Aging, 2, 243–253.

Roux, A. E., et al. (2022). Diverse Partial Reprogramming Strategies Restore Youthful Gene Expression and Transiently Suppress Cell Identity. Cell Systems, 13(7), 574–587.e11.

Parras, A., et al. (2023). In Vivo Reprogramming Leads to Premature Death Linked to Hepatic and Intestinal Failure. Nature Aging, 3(12), 1509–1520.

Yücel, A. D., & Gladyshev, V. N. (2024). The Long and Winding Road of Reprogramming-Induced Rejuvenation. Nature Communications, 15, 1941.

ClinicalTrials.gov. (2026). Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy. NCT07290244. Státusz ellenőrizve: 2026. augusztus 6.

Life Biosciences. (2026a). Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies. Vállalati közlemény, 2026. január 28.

Life Biosciences. (2026b). Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER-100 for Optic Neuropathies. Vállalati közlemény, 2026. június 9.

Hou, P., et al. (2013). Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds. Science, 341(6146), 651–654.

Guan, J., et al. (2022). Chemical Reprogramming of Human Somatic Cells to Pluripotent Stem Cells. Nature, 605, 325–331.

Yang, J. H., et al. (2023). Chemically Induced Reprogramming to Reverse Cellular Aging. Aging, 15(13), 5966–5989.

Sarkar, T. J., et al. (2020). Transient Non-Integrative Expression of Nuclear Reprogramming Factors Promotes Multifaceted Amelioration of Aging in Human Cells. Nature Communications, 11, 1545.

Gill, D., et al. (2022). Multi-Omic Rejuvenation of Human Cells by Maturation Phase Transient Reprogramming. eLife, 11, e71624.

Nuñez, J. K., et al. (2021). Genome-Wide Programmable Transcriptional Memory by CRISPR-Based Epigenome Editing. Cell, 184(10), 2503–2519.e17.

World Health Organization. (2021). Human Genome Editing: Recommendations. Geneva: World Health Organization.

Pupo, A., et al. (2022). AAV Vectors: The Rubik’s Cube of Human Gene Therapy. Molecular Therapy, 30(12), 3515–3541.

Homérosz. Iliász. XVIII. ének, 417–421. Magyar fordításban több kiadásban.

Jumper, J., et al. (2021). Highly Accurate Protein Structure Prediction with AlphaFold. Nature, 596, 583–589.

Tunyasuvunakool, K., et al. (2021). Highly Accurate Protein Structure Prediction for the Human Proteome. Nature, 596, 590–596.

Varadi, M., et al. (2022). AlphaFold Protein Structure Database: Massively Expanding the Structural Coverage of Protein-Sequence Space with High-Accuracy Models. Nucleic Acids Research, 50(D1), D439–D444.

AlphaFold Protein Structure Database. European Molecular Biology Laboratory – European Bioinformatics Institute and Google DeepMind. Online adatbázis; ellenőrizve: 2026. augusztus 6.

The Royal Swedish Academy of Sciences. (2024). The Nobel Prize in Chemistry 2024: Computational Protein Design and Protein Structure Prediction.

Abramson, J., et al. (2024). Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3. Nature, 630, 493–500.

Akdel, M., et al. (2022). A Structural Biology Community Assessment of AlphaFold2 Applications. Nature Structural & Molecular Biology, 29, 1056–1067.

Terwilliger, T. C., et al. (2024). AlphaFold Predictions Are Valuable Hypotheses and Accelerate but Do Not Replace Experimental Structure Determination. Nature Methods, 21, 110–116.

Dauparas, J., et al. (2022). Robust Deep Learning-Based Protein Sequence Design Using ProteinMPNN. Science, 378(6615), 49–56.

Watson, J. L., et al. (2023). De Novo Design of Protein Structure and Function with RFdiffusion. Nature, 620, 1089–1100.

Madani, A., et al. (2023). Large Language Models Generate Functional Protein Sequences across Diverse Families. Nature Biotechnology, 41, 1099–1106.

Mayr, A., et al. (2016). DeepTox: Toxicity Prediction Using Deep Learning. Frontiers in Environmental Science, 3, 80.

Vamathevan, J., et al. (2019). Applications of Machine Learning in Drug Discovery and Development. Nature Reviews Drug Discovery, 18, 463–477.

Zhavoronkov, A., et al. (2019). Deep Learning Enables Rapid Identification of Potent DDR1 Kinase Inhibitors. Nature Biotechnology, 37, 1038–1040.

Cao, Y., et al. (2019). Quantum Chemistry in the Age of Quantum Computing. Chemical Reviews, 119(19), 10856–10915.

Li, W., et al. (2024). A Hybrid Quantum Computing Pipeline for Real World Drug Discovery. Scientific Reports, 14, 17892.

Corral-Acero, J., et al. (2020). The “Digital Twin” to Enable the Vision of Precision Cardiology. European Heart Journal, 41(48), 4556–4564.

Katsoulakis, E., et al. (2024). Digital Twins for Health: A Scoping Review. npj Digital Medicine, 7, 77.

Sel, K., et al. (2024). Building Digital Twins for Cardiovascular Health: From Principles to Clinical Impact. Journal of the American Heart Association, 13, e031981.

Tudor, B. H., et al. (2025). A Scoping Review of Human Digital Twins in Healthcare Applications and Usage Patterns. npj Digital Medicine, 8, 587.

Kaissis, G. A., et al. (2020). Secure, Privacy-Preserving and Federated Machine Learning in Medical Imaging. Nature Machine Intelligence, 2, 305–311.

Dayan, I., et al. (2021). Federated Learning for Predicting Clinical Outcomes in Patients with COVID-19. Nature Medicine, 27, 1735–1743.

Bent, B., Goldstein, B. A., Kibbe, W. A., & Dunn, J. P. (2020). Investigating Sources of Inaccuracy in Wearable Optical Heart Rate Sensors. npj Digital Medicine, 3, 18.

Lee, T., et al. (2023). Accuracy of 11 Wearable, Nearable, and Airable Consumer Sleep Trackers: Prospective Multicenter Validation Study. JMIR mHealth and uHealth, 11, e50983.

Perez, M. V., et al. (2019). Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. New England Journal of Medicine, 381, 1909–1917.

Nahum-Shani, I., et al. (2018). Just-in-Time Adaptive Interventions in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support. Annals of Behavioral Medicine, 52(6), 446–462.

Baron, K. G., Abbott, S., Jao, N., Manalo, N., & Mullen, R. (2017). Orthosomnia: Are Some Patients Taking the Quantified Self Too Far? Journal of Clinical Sleep Medicine, 13(2), 351–354.

Bell, C. G., et al. (2019). DNA Methylation Aging Clocks: Challenges and Recommendations. Genome Biology, 20, 249.

World Health Organization. (2020). Screening Programmes: A Short Guide. Increase Effectiveness, Maximize Benefits and Minimize Harm. Copenhagen: WHO Regional Office for Europe.

U.S. National Cancer Institute. Questions and Answers about Multi-Cancer Detection Tests. Online szakmai összefoglaló; ellenőrizve: 2026. augusztus 6.

U.S. National Cancer Institute. The Vanguard Study on Multi-Cancer Detection Tests. Online vizsgálati tájékoztató; ellenőrizve: 2026. augusztus 6.

American College of Radiology. (2023). ACR Statement on Screening Total Body MRI.

Gibson, L. M., et al. (2018). Potentially Serious Incidental Findings on Brain and Body Magnetic Resonance Imaging of Apparently Asymptomatic Adults: Systematic Review and Meta-Analysis. BMJ, 363, k4577.

Kwee, R. M., & Kwee, T. C. (2019). Whole-Body MRI for Preventive Health Screening: A Systematic Review of the Literature. Journal of Magnetic Resonance Imaging, 50(5), 1489–1503.

Rajkomar, A., Dean, J., & Kohane, I. (2019). Machine Learning in Medicine. New England Journal of Medicine, 380, 1347–1358.

Finlayson, S. G., Subbaswamy, A., & Singh, K. (2021). The Clinician and Dataset Shift in Artificial Intelligence. New England Journal of Medicine, 385, 283–286.

Asgari, E., et al. (2025). A Framework to Assess Clinical Safety and Hallucination Rates of Large Language Models for Medical Text Summarisation. npj Digital Medicine, 8, 274.

Kücking, F., Hübner, U., Przysucha, M., et al. (2024). Automation Bias in AI-Decision Support: Results from an Empirical Study. Studies in Health Technology and Informatics, 317, 298–304.

World Health Organization. (2021). Ethics and Governance of Artificial Intelligence for Health. Geneva: World Health Organization.

World Health Organization. (2023). Regulatory Considerations on Artificial Intelligence for Health. Geneva: World Health Organization.

European Parliament and Council of the European Union. (2024). Regulation (EU) 2024/1689 Laying Down Harmonised Rules on Artificial Intelligence. Official Journal of the European Union, L 2024/1689.

U.S. Food and Drug Administration. (2025). Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations. Draft Guidance for Industry and Food and Drug Administration Staff.

Pseudo-Apollodórosz. Bibliothéké, 1.7.5.

Apollóniosz Rhodiosz. Argonautika, 4.55–64.

Pauszaniasz. Görögország leírása, 5.1.4.

Ovidius. Heroides, 18.61–65.

Parfit, D. (1984). Reasons and Persons. Oxford: Clarendon Press.

Schechtman, M. (1996). The Constitution of Selves. Ithaca, NY: Cornell University Press.

Olson, E. T. (2007). What Are We? A Study in Personal Ontology. Oxford: Oxford University Press.

Damasio, A. R. (1999). The Feeling of What Happens: Body and Emotion in the Making of Consciousness. New York: Harcourt Brace.

Spalding, K. L., Bhardwaj, R. D., Buchholz, B. A., et al. (2005). Retrospective Birth Dating of Cells in Humans. Cell, 122(1), 133–143. doi:10.1016/j.cell.2005.04.028.

Bergmann, O., Bhardwaj, R. D., Bernard, S., et al. (2009). Evidence for Cardiomyocyte Renewal in Humans. Science, 324(5923), 98–102. doi:10.1126/science.1164680.

Sender, R., & Milo, R. (2021). The Distribution of Cellular Turnover in the Human Body. Nature Medicine, 27, 45–48. doi:10.1038/s41591-020-01182-9.

Craig, A. D. (2009). How Do You Feel—Now? The Anterior Insula and Human Awareness. Nature Reviews Neuroscience, 10(1), 59–70. doi:10.1038/nrn2555.

Seth, A. K., & Friston, K. J. (2016). Active Interoceptive Inference and the Emotional Brain. Philosophical Transactions of the Royal Society B, 371(1708), 20160007. doi:10.1098/rstb.2016.0007.

Logothetis, N. K. (2008). What We Can Do and What We Cannot Do with fMRI. Nature, 453(7197), 869–878. doi:10.1038/nature06976.

Buzsáki, G., Anastassiou, C. A., & Koch, C. (2012). The Origin of Extracellular Fields and Currents—EEG, ECoG, LFP and Spikes. Nature Reviews Neuroscience, 13(6), 407–420. doi:10.1038/nrn3241.

Dehaene, S., & Changeux, J.-P. (2011). Experimental and Theoretical Approaches to Conscious Processing. Neuron, 70(2), 200–227. doi:10.1016/j.neuron.2011.03.018.

Tononi, G., Boly, M., Massimini, M., & Koch, C. (2016). Integrated Information Theory: From Consciousness to Its Physical Substrate. Nature Reviews Neuroscience, 17(7), 450–461. doi:10.1038/nrn.2016.44.

Seth, A. K., & Bayne, T. (2022). Theories of Consciousness. Nature Reviews Neuroscience, 23, 439–452. doi:10.1038/s41583-022-00587-4.

Cogitate Consortium, Ferrante, O., Gorska-Klimowska, U., et al. (2025). Adversarial Testing of Global Neuronal Workspace and Integrated Information Theories of Consciousness. Nature, 642, 133–142. doi:10.1038/s41586-025-08888-1.

Dorkenwald, S., Matsliah, A., Sterling, A. R., et al. (2024). Neuronal Wiring Diagram of an Adult Brain. Nature, 634, 124–138. doi:10.1038/s41586-024-07558-y.

Schlegel, P., Yin, Y., Bates, A. S., et al. (2024). Whole-Brain Annotation and Multi-Connectome Cell Typing of Drosophila. Nature, 634, 139–152. doi:10.1038/s41586-024-07686-5.

Shapson-Coe, A., Januszewski, M., Berger, D. R., et al. (2024). A Petavoxel Fragment of Human Cerebral Cortex Reconstructed at Nanoscale Resolution. Science, 384(6696), eadk4858. doi:10.1126/science.adk4858.

Shiu, P. K., Sterne, G. R., Engert, S., et al. (2024). A Drosophila Computational Brain Model Reveals Sensorimotor Processing. Nature, 634, 210–219. doi:10.1038/s41586-024-07763-9.

Kral, A., & O’Donoghue, G. M. (2010). Profound Deafness in Childhood. The New England Journal of Medicine, 363(15), 1438–1450. doi:10.1056/NEJMra0911225.

Kral, A. (2019). Cochlear Implants and Critical Periods. Brain Sciences, 9(2), 37. doi:10.3390/brainsci9020037.

Willett, F. R., Avansino, D. T., Hochberg, L. R., Henderson, J. M., & Shenoy, K. V. (2021). High-Performance Brain-to-Text Communication via Handwriting. Nature, 593, 249–254. doi:10.1038/s41586-021-03506-2.

Metzger, S. L., Littlejohn, K. T., Silva, A. B., et al. (2023). A High-Performance Neuroprosthesis for Speech Decoding and Avatar Control. Nature, 620, 1037–1046. doi:10.1038/s41586-023-06443-4.

Card, N. S., Wairagkar, M., Iacobacci, C., et al. (2024). An Accurate and Rapidly Calibrating Speech Neuroprosthesis. The New England Journal of Medicine, 391(7), 609–618. doi:10.1056/NEJMoa2314132.

Hampson, R. E., Song, D., Robinson, B. S., et al. (2018). Developing a Hippocampal Neural Prosthetic to Facilitate Human Memory Encoding and Recall. Journal of Neural Engineering, 15(3), 036014. doi:10.1088/1741-2552/aaaed7.

Roeder, B. M., Song, D., Dong, C., et al. (2024). Developing a Hippocampal Neural Prosthetic to Facilitate Human Memory Encoding and Recall of Stimulus Features and Categories. Frontiers in Computational Neuroscience, 18, 1263311. doi:10.3389/fncom.2024.1263311.

Sandberg, A., & Bostrom, N. (2008). Whole Brain Emulation: A Roadmap. Technical Report 2008-3. Oxford: Future of Humanity Institute, University of Oxford.

Puzio, A. (2023). When the Digital Continues after Death: Ethical Perspectives on Death Tech and the Digital Afterlife. Communicatio Socialis, 56(3), 427–436. doi:10.5771/0010-3497-2023-3-427.

Hollanek, T., & Nowaczyk-Basińska, K. (2024). Griefbots, Deadbots, Postmortem Avatars: On Responsible Applications of Generative AI in the Digital Afterlife Industry. Philosophy & Technology, 37, 63. doi:10.1007/s13347-024-00744-w.

Smirnova, L., Caffo, B. S., Gracias, D. H., et al. (2023). Organoid Intelligence: The New Frontier in Biocomputing and Intelligence-in-a-Dish. Frontiers in Science, 1, 1017235. doi:10.3389/fsci.2023.1017235.

Hartung, T., Morales Pantoja, I. E., & Smirnova, L. (2024). Brain Organoids and Organoid Intelligence from Ethical, Legal, and Social Points of View. Frontiers in Artificial Intelligence, 6, 1307613. doi:10.3389/frai.2023.1307613.

Storey, K. B., & Storey, J. M. (2017). Molecular Physiology of Freeze Tolerance in Vertebrates. Physiological Reviews, 97(2), 623–665. doi:10.1152/physrev.00016.2016.

Cerri, M., Tinganelli, W., Negrini, M., et al. (2021). Hibernation for Space Travel: Impact on Radioprotection. Life Sciences in Space Research, 30, 1–9. doi:10.1016/j.lssr.2021.05.001.

Fahy, G. M., MacFarlane, D. R., Angell, C. A., & Meryman, H. T. (1984). Vitrification as an Approach to Cryopreservation. Cryobiology, 21(4), 407–426. doi:10.1016/0011-2240(84)90079-8.

Fahy, G. M., Wowk, B., Wu, J., et al. (2004). Cryopreservation of Organs by Vitrification: Perspectives and Recent Advances. Cryobiology, 48(2), 157–178. doi:10.1016/j.cryobiol.2004.02.002.

Fahy, G. M., & Wowk, B. (2015). Principles of Cryopreservation by Vitrification. Methods in Molecular Biology, 1257, 21–82. doi:10.1007/978-1-4939-2193-5_2.

Giwa, S., Lewis, J. K., Alvarez, L., et al. (2017). The Promise of Organ and Tissue Preservation to Transform Medicine. Nature Biotechnology, 35, 530–542. doi:10.1038/nbt.3889.

Han, Z., Rao, J. S., Gangwar, L., et al. (2023). Vitrification and Nanowarming Enable Long-Term Organ Cryopreservation and Life-Sustaining Kidney Transplantation in a Rat Model. Nature Communications, 14, 3407. doi:10.1038/s41467-023-38824-8.

Gangwar, L., et al. (2025). Physical Vitrification and Nanowarming at Liter-Scale Cryoprotective-Agent Volumes: Toward Organ Cryopreservation. Nature Communications, 16. doi:10.1038/s41467-025-63483-2.

Tisherman, S. A., Alam, H. B., Rhee, P. M., et al. (2022). Emergency Preservation and Resuscitation for Cardiac Arrest from Trauma. Journal of Trauma and Acute Care Surgery, 92(2), 237–246. doi:10.1097/TA.0000000000003435.

ClinicalTrials.gov. Emergency Preservation and Resuscitation for Cardiac Arrest from Trauma. NCT01042015. Nyilvántartási adatlap; ellenőrizve: 2026. augusztus 6.

Remondelli, M. H., Nye, K., Wang, J., et al. (2026). Emergency Preservation and Resuscitation in Exsanguination Cardiac Arrest: Science Fiction to Future Reality? Trauma Surgery & Acute Care Open, 11(2), e002165. doi:10.1136/tsaco-2025-002165.

Vrselja, Z., Daniele, S. G., Silbereis, J., et al. (2019). Restoration of Brain Circulation and Cellular Functions Hours Post-Mortem. Nature, 568, 336–343. doi:10.1038/s41586-019-1099-1.

Andrijevic, D., Vrselja, Z., Lysyy, T., et al. (2022). Cellular Recovery after Prolonged Warm Ischaemia of the Whole Body. Nature, 608, 405–412. doi:10.1038/s41586-022-05016-1.

Society for Cryobiology. (2018). Position Statement: Cryonics. Baltimore: Society for Cryobiology.

Best, B. P. (2008). Scientific Justification of Cryonics Practice. Rejuvenation Research, 11(2), 493–503. doi:10.1089/rej.2008.0661. [A krionika mellett érvelő elméleti álláspont; a klinikai hatásosság kérdését fogalmi érvekkel tárgyalja.]

Moen, O. M. (2015). The Case for Cryonics. Journal of Medical Ethics, 41(8), 677–681. doi:10.1136/medethics-2015-102715. [Etikai-filozófiai érvelés; a forrás normatív szempontokat tárgyal.]

Parks Australia. (2026). Tjukurpa. Uluṟu–Kata Tjuṯa National Park. Online kulturális tájékoztató; ellenőrizve: 2026. augusztus 6.

Parks Australia. (2026). Aṉangu Culture. Uluṟu–Kata Tjuṯa National Park. Online kulturális tájékoztató; ellenőrizve: 2026. augusztus 6.

Rosa, H. (2013). Social Acceleration: A New Theory of Modernity. New York: Columbia University Press.

Giurge, L. M., Whillans, A. V., & West, C. (2020). Why Time Poverty Matters for Individuals, Organisations and Nations. Nature Human Behaviour, 4(10), 993–1003. doi:10.1038/s41562-020-0920-z.

Whillans, A. V., & West, C. (2022). Alleviating Time Poverty Among the Working Poor: A Pre-Registered Longitudinal Field Experiment. Scientific Reports, 12, 719. doi:10.1038/s41598-021-04352-y.

Hyde, E., Greene, M. E., & Darmstadt, G. L. (2020). Time Poverty: Obstacle to Women’s Human Rights, Health and Sustainable Development. Journal of Global Health, 10(2), 020313.

Rodgers, Y. van der M. (2023). Time Poverty: Conceptualization, Gender Differences, and Policy Solutions. Social Philosophy and Policy, 40(1), 79–102.

Wittmann, M., Dinich, J., Merrow, M., & Roenneberg, T. (2006). Social Jetlag: Misalignment of Biological and Social Time. Chronobiology International, 23(1–2), 497–509.

Roenneberg, T., Allebrandt, K. V., Merrow, M., & Vetter, C. (2012). Social Jetlag and Obesity. Current Biology, 22(10), 939–943. doi:10.1016/j.cub.2012.03.038.

World Health Organization. (2025). From Loneliness to Social Connection: Charting a Path to Healthier Societies. Report of the WHO Commission on Social Connection. Geneva: World Health Organization.

National Academies of Sciences, Engineering, and Medicine. (2020). Social Isolation and Loneliness in Older Adults: Opportunities for the Health Care System. Washington, DC: National Academies Press.

Berkman, L. F., Glass, T., Brissette, I., & Seeman, T. E. (2000). From Social Integration to Health: Durkheim in the New Millennium. Social Science & Medicine, 51(6), 843–857.

Holt-Lunstad, J., Smith, T. B., Baker, M., Harris, T., & Stephenson, D. (2015). Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Review. Perspectives on Psychological Science, 10(2), 227–237. doi:10.1177/1745691614568352.

Cole, S. W., Capitanio, J. P., Chun, K., Arevalo, J. M. G., Ma, J., & Cacioppo, J. T. (2015). Myeloid Differentiation Architecture of Leukocyte Transcriptome Dynamics in Perceived Social Isolation. Proceedings of the National Academy of Sciences, 112(49), 15142–15147. doi:10.1073/pnas.1514249112.

Cole, S. W. (2019). The Conserved Transcriptional Response to Adversity. Current Opinion in Behavioral Sciences, 28, 31–37.

Granovetter, M. S. (1973). The Strength of Weak Ties. American Journal of Sociology, 78(6), 1360–1380.

Sandstrom, G. M., & Dunn, E. W. (2014). Social Interactions and Well-Being: The Surprising Power of Weak Ties. Personality and Social Psychology Bulletin, 40(7), 910–922. doi:10.1177/0146167214529799.

Kiely, B., Croke, A., O’Shea, M., Boland, F., O’Shea, E., Connolly, D., & Smith, S. M. (2022). Effect of Social Prescribing Link Workers on Health Outcomes and Costs for Adults in Primary Care and Community Settings: A Systematic Review. BMJ Open, 12(10), e062951. doi:10.1136/bmjopen-2022-062951.

Wild, C. P. (2005). Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology. Cancer Epidemiology, Biomarkers & Prevention, 14(8), 1847–1850. doi:10.1158/1055-9965.EPI-05-0456.

Vermeulen, R., Schymanski, E. L., Barabási, A.-L., & Miller, G. W. (2020). The Exposome and Health: Where Chemistry Meets Biology. Science, 367(6476), 392–396. doi:10.1126/science.aay3164.

Hajat, A., Hsia, C., & O’Neill, M. S. (2015). Socioeconomic Disparities and Air Pollution Exposure: A Global Review. Current Environmental Health Reports, 2, 440–450.

World Health Organization. (2021). WHO Global Air Quality Guidelines: Particulate Matter (PM2.5 and PM10), Ozone, Nitrogen Dioxide, Sulfur Dioxide and Carbon Monoxide. Geneva: World Health Organization.

World Health Organization Regional Office for Europe. (2018). Environmental Noise Guidelines for the European Region. Copenhagen: WHO Regional Office for Europe.

World Health Organization. (2026). Heat and Health. Online szakmai összefoglaló, 2026. július 13.; ellenőrizve: 2026. augusztus 6.

World Health Organization Regional Office for Europe. (2026). Heat–Health Action Plans: Guidance. 2nd ed. Copenhagen: WHO Regional Office for Europe.

Twohig-Bennett, C., & Jones, A. (2018). The Health Benefits of the Great Outdoors: A Systematic Review and Meta-Analysis of Greenspace Exposure and Health Outcomes. Environmental Research, 166, 628–637. doi:10.1016/j.envres.2018.06.030.

Radácsi, L., Czédli, H., Major, Z., & Szigeti, C. (2026). Grassed Tramway Tracks and Sustainable Urban Mobility: Integrating Nature-based Solutions in City Transport Infrastructure. Acta Polytechnica Hungarica, 23(1), 271–286. doi:10.12700/APH.23.1.2026.1.16.

FAO, UNEP, WHO, & WOAH. (2022). One Health Joint Plan of Action (2022–2026): Working Together for the Health of Humans, Animals, Plants and the Environment. Rome and Geneva.

World Health Organization. (2007). Global Age-Friendly Cities: A Guide. Geneva: World Health Organization.

World Health Organization. (2015). World Report on Ageing and Health. Geneva: World Health Organization.

World Health Organization. (2020). Healthy Ageing and Functional Ability. Online szakmai összefoglaló.

Wiles, J. L., Leibing, A., Guberman, N., Reeve, J., & Allen, R. E. S. (2012). The Meaning of “Aging in Place” to Older People. The Gerontologist, 52(3), 357–366.

Szanton, S. L., et al. (2014). CAPABLE Trial: A Randomized Controlled Trial of Nurse, Occupational Therapist and Handyman to Reduce Disability Among Older Adults: Rationale and Design. Contemporary Clinical Trials, 38(1), 102–112. doi:10.1016/j.cct.2014.03.005.

Szanton, S. L., et al. (2019). Effect of a Biobehavioral Environmental Approach on Disability Among Low-Income Older Adults: A Randomized Clinical Trial. JAMA Internal Medicine, 179(2), 204–211. doi:10.1001/jamainternmed.2018.6026.

Housing & Development Board, Singapore. (2026). Kampung Admiralty. Online projektismertető; ellenőrizve: 2026. augusztus 6.

Prime Minister’s Office Singapore. (2018). PM Lee Hsien Loong at the Opening of Kampung Admiralty. 12 May 2018.

Krzeczkowska, A., Spalding, D. M., McGeown, W. J., Gow, A. J., Carlson, M. C., Nicholls, L. A. B., & Elliott, E. (2021). A Systematic Review of the Impacts of Intergenerational Engagement on Older Adults’ Cognitive, Social, and Health Outcomes. Ageing Research Reviews, 71, 101400. doi:10.1016/j.arr.2021.101400.

Carlson, M. C., et al. (2009). Evidence for Neurocognitive Plasticity in At-Risk Older Adults: The Experience Corps Program. The Journals of Gerontology: Series A, 64A(12), 1275–1282. doi:10.1093/gerona/glp117.

Fried, L. P., et al. (2004). A Social Model for Health Promotion for an Aging Population: Initial Evidence on the Experience Corps Model. Journal of Urban Health, 81(1), 64–78.

Kaplan, M., Sánchez, M., & Hoffman, J. (2017). Intergenerational Pathways to a Sustainable Society. Cham: Springer.

Pseudo-Apollodorus. Bibliotheca, 3.5.8.

Gantz, T. (1993). Early Greek Myth: A Guide to Literary and Artistic Sources. Baltimore: Johns Hopkins University Press.

Kohli, M. (1986). The World We Forgot: A Historical Review of the Life Course. In V. W. Marshall (Ed.), Later Life: The Social Psychology of Aging. Beverly Hills: Sage.

Gratton, L., & Scott, A. J. (2016). The 100-Year Life: Living and Working in an Age of Longevity. London: Bloomsbury.

United Nations, Department of Economic and Social Affairs, Population Division. (2024). World Population Prospects 2024: Summary of Results. New York: United Nations.

European Commission, Directorate-General for Economic and Financial Affairs, & Economic Policy Committee. (2024). The 2024 Ageing Report: Economic and Budgetary Projections for the EU Member States (2022–2070). Institutional Paper 279. Luxembourg: Publications Office of the European Union. https://doi.org/10.2765/022983

Központi Statisztikai Hivatal. (2026). Egészségesen várható élettartam (STADAT 4.1.1.44.). 2025. évi adatok.

World Health Organization. (2015). World Report on Ageing and Health. Geneva: WHO.

Marmot, M., Allen, J., Boyce, T., Goldblatt, P., & Morrison, J. (2020). Health Equity in England: The Marmot Review 10 Years On. London: Institute of Health Equity.

International Monetary Fund. (2025). The Rise of the Silver Economy: Global Implications of Population Aging. In World Economic Outlook, April 2025, Chapter 2. Washington, DC: IMF.

Goldman, D. P., Cutler, D., Rowe, J. W., Michaud, P.-C., Sullivan, J., Peneva, D., & Olshansky, S. J. (2013). Substantial Health and Economic Returns from Delayed Aging May Warrant a New Focus for Medical Research. Health Affairs, 32(10), 1698–1705.

Scott, A. J., Ellison, M., & Sinclair, D. A. (2021). The Economic Value of Targeting Aging. Nature Aging, 1, 616–623.

Olshansky, S. J., Perry, D., Miller, R. A., & Butler, R. N. (2007). Pursuing the Longevity Dividend: Scientific Goals for an Aging World. Annals of the New York Academy of Sciences, 1114, 11–13.

International Labour Organization. (2018). Care Work and Care Jobs for the Future of Decent Work. Geneva: ILO.

OECD. (2023a). Health at a Glance 2023: OECD Indicators. Paris: OECD Publishing.

OECD. (2023b). Beyond Applause? Improving Working Conditions in Long-Term Care. Paris: OECD Publishing.

European Commission, Social Protection Committee. (2024). Annual Report 2024: Review of the Social Protection Performance Monitor and Developments in Social Protection Policies. Thematic focus: long-term care. Brussels: European Commission.

OECD. (2019). Working Better with Age. Paris: OECD Publishing.

OECD. (2025). OECD Employment Outlook 2025: Can We Get Through the Demographic Crunch? Paris: OECD Publishing.

OECD. (2025). Staying in the Game: Skills and Jobs of Older Workers in a Changing Labour Market. In OECD Employment Outlook 2025.

Neumark, D., Burn, I., & Button, P. (2019). Is It Harder for Older Workers to Find Jobs? New and Improved Evidence from a Field Experiment. Journal of Political Economy, 127(2), 922–970.

Polanyi, M. (1966). The Tacit Dimension. Chicago: University of Chicago Press.

Nonaka, I. (1994). A Dynamic Theory of Organizational Knowledge Creation. Organization Science, 5(1), 14–37.

OECD. (2024). Do Adults Have the Skills They Need to Thrive in a Changing World? Survey of Adult Skills 2023. Paris: OECD Publishing.

Council of the European Union. (2022). Council Recommendation on a European Approach to Micro-Credentials for Lifelong Learning and Employability. Official Journal of the European Union, C 243/10.

European Commission. (2025). Progress Report on the Implementation of the Council Recommendation on a European Approach to Micro-Credentials for Lifelong Learning and Employability. Brussels: European Commission.

Cedefop. (2023). European Guidelines for Validating Non-Formal and Informal Learning. 3rd ed. Luxembourg: Publications Office of the European Union.

National Academies of Sciences, Engineering, and Medicine. (2017). Preventing Cognitive Decline and Dementia: A Way Forward. Washington, DC: National Academies Press.

Livingston, G., et al. (2024). Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission. The Lancet, 404, 572–628.

Glass, P.-Y. (1995. december 29.). It Was A Great Deal But Not For Him: 120-Year-Old Turns Tables In Real Estate Gamble. Associated Press, republished by The Spokesman-Review.

Robine, J.-M., & Allard, M. (1999). Jeanne Calment: Validation of the Duration of Her Life. In B. Jeune & J. W. Vaupel (Eds.), Validation of Exceptional Longevity (Odense Monographs on Population Aging, Vol. 6, pp. 145–172). Odense University Press.

OECD. (2014). Mortality Assumptions and Longevity Risk: Implications for Pension Funds and Annuity Providers. Paris: OECD Publishing.

OECD. (2017). Flexible Retirement in OECD Countries. In Pensions at a Glance 2017. Paris: OECD Publishing.

OECD. (2025). Pensions at a Glance 2025: OECD and G20 Indicators. Paris: OECD Publishing. https://doi.org/10.1787/e40274c1-en

European Commission & Social Protection Committee. (2024). Pension Adequacy Report 2024: Current and Future Income Adequacy in Old Age in the EU. Volumes I–II. Luxembourg: Publications Office of the European Union.

OECD. (2020). Financial Consumer Protection and Ageing Populations. Paris: OECD Publishing. https://doi.org/10.1787/1de27f2a-en

OECD. (2026). Consumer Finance Risk Monitor 2026. Paris: OECD Publishing. https://doi.org/10.1787/61f7dbe0-en

European Insurance and Occupational Pensions Authority. (2021). Artificial Intelligence Governance Principles: Towards Ethical and Trustworthy Artificial Intelligence in the European Insurance Sector. Frankfurt: EIOPA.

European Insurance and Occupational Pensions Authority. (2025). Opinion on Artificial Intelligence Governance and Risk Management. Frankfurt: EIOPA.

Ovidius. Metamorphoses. XI. könyv, 85–145. Több magyar kiadásban Átváltozások címmel.

Sandel, M. J. (2007). The Case Against Perfection: Ethics in the Age of Genetic Engineering. Cambridge, MA: Harvard University Press.

de Grey (2004), Escape Velocity: Why the Prospect of Extreme Human Life Extension Matters Now;

National Academy of Medicine. (2022). Global Roadmap for Healthy Longevity. Washington, DC: The National Academies Press.

Kennedy, B. K., Berger, S. L., Brunet, A., et al. (2014). Geroscience: Linking Aging to Chronic Disease. Cell, 159(4), 709–713. https://doi.org/10.1016/j.cell.2014.10.039

FDA–NIH Biomarker Working Group. (2016, frissített online kiadás). BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring, MD, and Bethesda, MD.

Justice, J. N., et al. (2016). Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes. The Journals of Gerontology: Series A, 71(11), 1415–1423. https://doi.org/10.1093/gerona/glw126

Justice, J. N., Ferrucci, L., Newman, A. B., et al. (2018). A Framework for Selection of Blood-Based Biomarkers for Geroscience-Guided Clinical Trials. GeroScience, 40(5–6), 419–436. https://doi.org/10.1007/s11357-018-0042-y

Kwee, R. M., & Kwee, T. C. (2019). Whole-Body MRI for Preventive Health Screening: A Systematic Review of the Literature. Journal of Magnetic Resonance Imaging, 50(5), 1489–1503. https://doi.org/10.1002/jmri.26736

World Health Organization Regional Office for Europe. (2020). Screening Programmes: A Short Guide. Increase Effectiveness, Maximize Benefits and Minimize Harm. Copenhagen: WHO Regional Office for Europe.

Higgins-Chen, A. T., Thrush, K. L., Wang, Y., et al. (2022). A Computational Solution for Bolstering Reliability of Epigenetic Clocks: Implications for Clinical Trials and Longitudinal Tracking. Nature Aging, 2, 644–661.

Bonnes, S. L. R., Strauss, T., Palmer, A. K., et al. (2024). Establishing Healthy Longevity Clinics in Publicly Funded Hospitals. GeroScience, 46(5), 4217–4223. https://doi.org/10.1007/s11357-024-01132-0

Olshansky és munkatársai (2024), Implausibility of Radical Life Extension in Humans in the Twenty-First Century.

Mironov, S., Borysova, O., Morgunov, I., Zhou, Z., & Moskalev, A. (2025). A Framework for an Effective Healthy Longevity Clinic. Aging and Disease, 16(4), 1971–1986. https://doi.org/10.14336/AD.2024.0328-1

Demaria, M. (2025). Longevity Clinics: Between Promise and Peril. Aging, 17(10), 2452–2454. https://doi.org/10.18632/aging.206330

Bischof, E., Wilczok, D., Kirkland, J. L., et al. (2026). Upskilling in Healthy Longevity Medicine and Its Association With Physicians’ Implementation Intent and Self-Reported Clinical Confidence: Cross-Sectional Observational Study. JMIR Medical Education, 12, e83779. https://doi.org/10.2196/83779

World Health Organization. (2021). Ethics and Governance of Artificial Intelligence for Health. Geneva: WHO.

Sampat, B. N., & Lichtenberg, F. R. (2011). What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation? Health Affairs, 30(2), 332–339. https://doi.org/10.1377/hlthaff.2009.0917

Mazzucato, M. (2013). The Entrepreneurial State. London: Anthem Press.

Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012). Diagnosing the Decline in Pharmaceutical R&D Efficiency. Nature Reviews Drug Discovery, 11, 191–200. https://doi.org/10.1038/nrd3681

Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014). Clinical Development Success Rates for Investigational Drugs. Nature Biotechnology, 32, 40–51. https://doi.org/10.1038/nbt.2786

Wong, C. H., Siah, K. W., & Lo, A. W. (2019). Estimation of Clinical Trial Success Rates and Related Parameters. Biostatistics, 20(2), 273–286. https://doi.org/10.1093/biostatistics/kxx069

International Council for Harmonisation. (2025). ICH E6(R3): Guideline for Good Clinical Practice. Final version, adopted 6 January 2025.

Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in Peptide Drug Discovery. Nature Reviews Drug Discovery, 20(4), 309–325. https://doi.org/10.1038/s41573-020-00135-8

Európai Parlament és Tanács. (2001). 2001/83/EK irányelv az emberi felhasználásra szánt gyógyszerek közösségi kódexéről. Az Európai Közösségek Hivatalos Lapja, L 311, 67–128, későbbi módosításokkal.

U.S. Food and Drug Administration. Compounding and the Section 503A Bulks List. Frissülő intézményi oldal; ellenőrizve: 2026. augusztus 6.

U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. Frissülő intézményi oldal; ellenőrizve: 2026. augusztus 6.

U.S. Food and Drug Administration. (2026a). July 23–24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. Meeting page, final agenda, questions, presentations, seven molecule-specific briefing documents and archived webcasts.

DLA Piper. (2026). FDA Advisory Committee Recommends Six Peptides for Addition to the Section 503A Bulks List. Legal analysis, 2026. július.

U.S. Food and Drug Administration. (2026b). FDA Publishes Revised Draft Product-Specific Guidances for Certain Generic Peptide Products. 2026. július 28.

Chetty, R., Stepner, M., Abraham, S., et al. (2016). The Association Between Income and Life Expectancy in the United States, 2001–2014. JAMA, 315(16), 1750–1766. https://doi.org/10.1001/jama.2016.4226

Marmot, M., Allen, J., Boyce, T., Goldblatt, P., & Morrison, J. (2020). Health Equity in England: The Marmot Review 10 Years On. London: Institute of Health Equity.

Radácsi, L. (2025). Az egészséges élettartam meghosszabbításának társadalmi megítélése Magyarországon – biogerontológiai ígéretek, attitűdök, hozzáférési preferenciák és fenntarthatósági aggodalmak. Századvég, 2025/3, 87–115. https://doi.org/10.65295/SZF.2025.3-4

OECD. (2011). Medical Tourism: Treatments, Markets and Health System Implications. Paris: OECD.

World Health Organization. (2024). Global Patient Safety Report 2024. Geneva: WHO.

Homérosz. Odüsszeia, XI. ének, 593–600. Különböző magyar kiadásokban.

Camus, A. (1942). Le Mythe de Sisyphe. Paris: Gallimard.

Seneca, L. A. De Brevitate Vitae. Magyarul: Az élet rövidségéről. Több magyar kiadásban.

Seneca, L. A. Epistulae Morales ad Lucilium, 1. Magyarul: Erkölcsi levelek. Több magyar kiadásban.

Montaigne, M. de. Esszék, I. könyv, 20. fejezet: Bölcselkedni annyi, mint megtanulni meghalni.

Heidegger, M. (1927). Sein und Zeit. Tübingen: Max Niemeyer.

Čapek, K. (1922). Věc Makropulos. Prague: Aventinum.

Williams, B. (1973). The Makropulos Case: Reflections on the Tedium of Immortality. In Problems of the Self: Philosophical Papers 1956–1972 (pp. 82–100). Cambridge: Cambridge University Press.

Burley, M. (2009). Immortality and Meaning: Reflections on the Makropulos Debate. Philosophy, 84(4), 529–547. https://doi.org/10.1017/S0031819109990106

Hauskeller, M. (2021). When Death Comes Too Late: Radical Life Extension and the Makropulos Case. Royal Institute of Philosophy Supplement, 90, 147–166.

Plutarkhosz. Thészeusz élete, 23. In Párhuzamos életrajzok.

Parfit, D. (1984). Reasons and Persons. Oxford: Clarendon Press.

Schechtman, M. (1996). The Constitution of Selves. Ithaca, NY: Cornell University Press.

Spalding, K. L., Bhardwaj, R. D., Buchholz, B. A., et al. (2005). Retrospective Birth Dating of Cells in Humans. Cell, 122(1), 133–143. https://doi.org/10.1016/j.cell.2005.04.028

Bergmann, O., Zdunek, S., Felker, A., et al. (2015). Dynamics of Cell Generation and Turnover in the Human Heart. Cell, 161(7), 1566–1575. https://doi.org/10.1016/j.cell.2015.05.026

Bostrom, N. (2005). The Fable of the Dragon-Tyrant. Journal of Medical Ethics, 31(5), 273–277. https://doi.org/10.1136/jme.2004.009035

Kass, L. R. (2003). Ageless Bodies, Happy Souls: Biotechnology and the Pursuit of Perfection. The New Atlantis, 1, 9–28.

Fukuyama, F. (2002). Our Posthuman Future: Consequences of the Biotechnology Revolution. New York: Farrar, Straus and Giroux.

Sandel, M. J. (2007). The Case Against Perfection: Ethics in the Age of Genetic Engineering. Cambridge, MA: Harvard University Press.

World Health Organization. (2015). World Report on Ageing and Health. Geneva: World Health Organization.

Malthus, T. R. (1798). An Essay on the Principle of Population. London: J. Johnson.

Vonnegut, K., Jr. (1954). The Big Trip Up Yonder. Galaxy Science Fiction, January, 100–110.

Rawls, J. (1971). A Theory of Justice. Cambridge, MA: Harvard University Press.

Gosseries, A., & Meyer, L. H. (Eds.). (2009). Intergenerational Justice. Oxford: Oxford University Press.

Tremmel, J. C. (2009). A Theory of Intergenerational Justice. London: Earthscan.

Scheffler, S. (2013). Death and the Afterlife. New York: Oxford University Press.

United Nations, Department of Economic and Social Affairs, Population Division. (2024). World Population Prospects 2024. New York: United Nations.

Radácsi, L. (2025). Az egészséges élettartam meghosszabbításának társadalmi megítélése Magyarországon – biogerontológiai ígéretek, attitűdök, hozzáférési preferenciák és fenntarthatósági aggodalmak. Századvég, 2025(3), 87–115. https://doi.org/10.65295/SZF.2025.3-4

Arisztotelész. (2023). Nikomakhoszi etika. Budapest: Atlantisz Könyvkiadó. Fordította Simon Attila.

Ryff, C. D. (1989). Happiness Is Everything, or Is It? Explorations on the Meaning of Psychological Well-Being. Journal of Personality and Social Psychology, 57(6), 1069–1081. https://doi.org/10.1037/0022-3514.57.6.1069

Ryff, C. D., & Keyes, C. L. M. (1995). The Structure of Psychological Well-Being Revisited. Journal of Personality and Social Psychology, 69(4), 719–727. https://doi.org/10.1037/0022-3514.69.4.719

Levy, B. R., Slade, M. D., Kunkel, S. R., & Kasl, S. V. (2002). Longevity Increased by Positive Self-Perceptions of Aging. Journal of Personality and Social Psychology, 83(2), 261–270. https://doi.org/10.1037/0022-3514.83.2.261

World Health Organization. (2021). Global Report on Ageism. Geneva: World Health Organization.

Sias, R., & Turtle, H. (2026). The Importance of Baseline Health in Linking Life Purpose to Longevity. PLOS ONE, 21(5), e0349401. https://doi.org/10.1371/journal.pone.0349401

Callaway, H. (1868). The Religious System of the Amazulu. Part I: Unkulunkulu; or, The Tradition of Creation as Existing among the Amazulu and Other Tribes of South Africa. Springvale: John A. Blair.

Homeric Hymn to Aphrodite, 218–238. In West, M. L. (Ed.). (2003). Homeric Hymns, Homeric Apocrypha, Lives of Homer. Cambridge, MA: Harvard University Press.

World Health Organization. (2015). World Report on Ageing and Health. Geneva: World Health Organization.